| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modification-dependent protein binding | ZCWPW1 ANK3 PARP2 BRD3 CBX4 JARID2 SETD5 MLLT1 TAF1 EP300 RAD23B | 4.60e-07 | 206 | 150 | 11 | GO:0140030 |
| GeneOntologyMolecularFunction | histone binding | ZCWPW1 RBBP5 ZNF689 BAZ1B NCL BRD3 CBX4 SETD5 MLLT1 CHD6 TAF1 | 5.35e-06 | 265 | 150 | 11 | GO:0042393 |
| GeneOntologyMolecularFunction | chromatin binding | CEBPB PARP2 NSD1 BRD3 CBX4 HNRNPU JARID2 H1-8 PBRM1 BRCA1 NFE2L1 H1-2 H1-4 MLLT1 CHD6 TAF1 TOP1 EP300 | 1.14e-05 | 739 | 150 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DCAF1 NOLC1 ZCWPW1 ANK3 GAS2L3 NSD1 NAPG HMGB1 BRD3 ZC3H18 CBX4 HNRNPU MAPK8IP3 BCLAF3 NEFH JARID2 BRCA1 SETD5 SUB1 ARID5B SPEN EP300 | 5.58e-05 | 1160 | 150 | 22 | GO:0030674 |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 6.95e-05 | 134 | 150 | 7 | GO:0003697 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF23 MYH13 ANK3 GAS2L3 MAP2 EML4 APC RGS2 HNRNPU MAPK8IP3 NEFH AFAP1 DST BRCA1 MICALL2 NAV3 CDK5RAP2 EML1 PALLD IQGAP3 EP300 | 7.54e-05 | 1099 | 150 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 8.22e-05 | 31 | 150 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | tubulin binding | KIF23 GAS2L3 MAP2 EML4 APC RGS2 NEFH DST BRCA1 NAV3 CDK5RAP2 EML1 | 9.69e-05 | 428 | 150 | 12 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | 1.15e-04 | 308 | 150 | 10 | GO:0008017 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | DCAF1 NOLC1 ZCWPW1 ANK3 GAS2L3 NSD1 NAPG HMGB1 BRD3 ZC3H18 CBX4 DZIP1 HNRNPU MAPK8IP3 BCLAF3 NEFH JARID2 BRCA1 SETD5 SUB1 ARID5B SPEN EP300 | 1.98e-04 | 1356 | 150 | 23 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.73e-04 | 167 | 150 | 7 | GO:0031490 | |
| GeneOntologyMolecularFunction | mRNA m(6)A methyltransferase activity | 3.33e-04 | 4 | 150 | 2 | GO:0001734 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.45e-04 | 229 | 150 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 4.29e-04 | 84 | 150 | 5 | GO:0003684 | |
| GeneOntologyMolecularFunction | transcription factor binding | DCAF1 NOLC1 CEBPB NSD1 UBA2 HMGB1 SALL4 HNRNPU PYHIN1 JARID2 CHD6 TAF1 SPEN EP300 RAD23B | 5.59e-04 | 753 | 150 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | supercoiled DNA binding | 8.24e-04 | 6 | 150 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.06e-03 | 27 | 150 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.45e-03 | 30 | 150 | 3 | GO:0070577 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | DCAF1 ARID4B RBBP5 PARP2 NSD1 BAZ1B HMGB1 BRD3 HNRNPU JARID2 H1-8 PBRM1 BRCA1 SETD5 BRPF1 H1-2 H1-4 CHD6 TAF1 TOP1 EP300 | 7.89e-08 | 741 | 148 | 21 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | DCAF1 ARID4B RBBP5 PARP2 NSD1 BAZ1B HMGB1 BRD3 CBX4 HNRNPU JARID2 H1-8 PBRM1 BRCA1 SETD5 BRPF1 H1-2 H1-4 CHD6 TAF1 TOP1 EP300 | 4.44e-07 | 896 | 148 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromosome organization | PTTG1 KIF23 ZCWPW1 WAPL EML4 APC BAZ1B HMGB1 AKAP8L HNRNPU H1-8 PBRM1 SUB1 H1-2 H1-4 CDK5RAP2 TOP1 MAJIN | 2.17e-06 | 686 | 148 | 18 | GO:0051276 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | DCAF1 ARID4B RBBP5 PARP2 NSD1 BAZ1B HMGB1 BRD3 CBX4 HNRNPU JARID2 H1-8 PBRM1 BRCA1 SETD5 BRPF1 H1-2 H1-4 CHD6 TAF1 TOP1 EP300 | 2.68e-06 | 999 | 148 | 22 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromosome segregation | PTTG1 KIF23 ZCWPW1 WAPL EML4 APC BAZ1B AKAP8L HNRNPU PBRM1 BRCA1 CDK5RAP2 TOP1 MAJIN | 6.77e-06 | 465 | 148 | 14 | GO:0007059 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | PTTG1 KIF23 ZCWPW1 WAPL EML4 APC BAZ1B AKAP8L HNRNPU PBRM1 CDK5RAP2 MAJIN | 1.04e-05 | 356 | 148 | 12 | GO:0098813 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | THAP5 DCAF1 CEBPB ARID4B TRPS1 NSD1 HMGB1 SALL4 CBX4 HNRNPU JARID2 AEBP1 NFE2L1 H1-2 ARID5B H1-4 PLAGL1 ZFHX3 TAF1 SPEN EP300 | 2.08e-05 | 1053 | 148 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | chromosome condensation | 2.37e-05 | 48 | 148 | 5 | GO:0030261 | |
| GeneOntologyBiologicalProcess | organelle fission | PTTG1 KIF23 ZCWPW1 WAPL EML4 APC BAZ1B AKAP8L HNRNPU NFE2L1 RALBP1 CDK5RAP2 MEIOSIN MAJIN | 6.50e-05 | 571 | 148 | 14 | GO:0048285 |
| GeneOntologyBiologicalProcess | nuclear division | PTTG1 KIF23 ZCWPW1 WAPL EML4 APC BAZ1B AKAP8L HNRNPU NFE2L1 CDK5RAP2 MEIOSIN MAJIN | 8.45e-05 | 512 | 148 | 13 | GO:0000280 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 9.36e-05 | 254 | 148 | 9 | GO:0000819 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 1.23e-04 | 107 | 148 | 6 | GO:2001251 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 1.50e-04 | 212 | 148 | 8 | GO:0000070 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.55e-04 | 38 | 148 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | THAP5 DCAF1 CEBPB ARID4B TRPS1 NSD1 HMGB1 SALL4 CBX4 HNRNPU JARID2 BRCA1 AEBP1 SETD5 NFE2L1 H1-2 ARID5B H1-4 PLAGL1 ZFHX3 TAF1 SPEN EP300 | 1.59e-04 | 1399 | 148 | 23 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | THAP5 DCAF1 CEBPB ARID4B TRPS1 NSD1 HMGB1 SALL4 CBX4 HNRNPU JARID2 BRCA1 AEBP1 SETD5 NFE2L1 H1-2 ARID5B H1-4 PLAGL1 ZFHX3 TAF1 SPEN EP300 | 1.84e-04 | 1413 | 148 | 23 | GO:1902679 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | KIF23 ANK3 GAS2L3 MAP2 EML4 APC DZIP1 HNRNPU NEFH DST BRCA1 NAV3 CDK5RAP2 EML1 SPAG17 | 2.15e-04 | 720 | 148 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 2.30e-04 | 42 | 148 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | thigmotaxis | 3.04e-04 | 4 | 148 | 2 | GO:0001966 | |
| GeneOntologyBiologicalProcess | muscle organ development | SCN11A ZNF689 EGLN1 STAC3 KLHL41 HIVEP3 ARID5B SCN8A PLAGL1 ZFHX3 EP300 | 3.17e-04 | 436 | 148 | 11 | GO:0007517 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 NOLC1 ELOA CEBPB ARID4B RBBP5 SF3A1 AFF3 NSD1 UBA2 BAZ1B NCL CBX4 ADAR HNRNPU BCLAF3 INTS10 JARID2 SNIP1 PBRM1 BRCA1 SETD5 RBM5 MLLT1 BOD1L1 NUP188 TAF1 AFF4 RAD23B | 1.40e-07 | 1377 | 150 | 29 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | THAP5 WAPL CEBPB ARID4B TRPS1 NSD1 BAZ1B SALL4 BRD3 AKAP8L JARID2 H1-8 PBRM1 BBX SETD5 NFE2L1 BRPF1 H1-2 H1-4 ANKRD11 ELF1 ZFHX3 CHD6 TAF1 EP300 AFF4 | 1.84e-05 | 1480 | 150 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear body | NOLC1 TPP2 SF3A1 AFF3 ZC3H18 CBX4 DZIP1 ADAR AKAP8L HNRNPU PYHIN1 BRCA1 RALBP1 SLTM TENM1 PLAGL1 ZFHX3 REXO1L1P | 8.62e-05 | 903 | 150 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | methyltransferase complex | 1.29e-04 | 108 | 150 | 6 | GO:0034708 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.05e-04 | 75 | 150 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF23 MYH13 ANK3 GAS2L3 MAP2 EML4 FBF1 APC KLHL41 HNRNPU CEP170 NEFH AFAP1 DST SCN8A NAV3 CDK5RAP2 EML1 SPAG17 PALLD | 3.00e-04 | 1179 | 150 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF23 MYH13 ANK3 GAS2L3 MAP2 EML4 FBF1 APC KLHL41 HNRNPU CEP170 NEFH AFAP1 DST SCN8A NAV3 CDK5RAP2 EML1 SPAG17 PALLD | 3.27e-04 | 1187 | 150 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule | KIF23 GAS2L3 MAP2 EML4 APC HNRNPU CEP170 DST NAV3 CDK5RAP2 EML1 SPAG17 | 4.76e-04 | 533 | 150 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 7.00e-04 | 56 | 150 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 7.39e-04 | 269 | 150 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF23 GAS2L3 MAP2 EML4 FBF1 APC HNRNPU CEP170 NEFH AFAP1 DST NAV3 CDK5RAP2 EML1 SPAG17 PALLD | 7.51e-04 | 899 | 150 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | super elongation complex | 7.53e-04 | 6 | 150 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 7.53e-04 | 6 | 150 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | fibrillar center | 9.28e-04 | 156 | 150 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | dense fibrillar component | 1.05e-03 | 7 | 150 | 2 | GO:0001651 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.12e-03 | 287 | 150 | 8 | GO:0035770 | |
| GeneOntologyCellularComponent | axon initial segment | 1.15e-03 | 29 | 150 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.49e-03 | 171 | 150 | 6 | GO:0034399 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | DCAF1 KIF23 FBF1 APC KLHL41 CBX4 DZIP1 HNRNPU CEP170 CSDE1 BRCA1 BRPF1 EIF2B3 TAF1 EP300 RAD23B | 1.69e-03 | 972 | 150 | 16 | GO:0140535 |
| GeneOntologyCellularComponent | euchromatin | 1.79e-03 | 72 | 150 | 4 | GO:0000791 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 2.22e-03 | 10 | 150 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | basal dendrite | 2.22e-03 | 10 | 150 | 2 | GO:0097441 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.43e-03 | 254 | 150 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | microtubule end | 2.54e-03 | 38 | 150 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | gamma-tubulin ring complex | 2.70e-03 | 11 | 150 | 2 | GO:0000931 | |
| HumanPheno | Micrognathia | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 TAF1 SPEN EP300 AFF4 | 3.31e-07 | 843 | 51 | 24 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 TAF1 SPEN EP300 AFF4 | 3.46e-07 | 845 | 51 | 24 | HP:0009118 |
| HumanPheno | Abnormal mandible morphology | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR JARID2 SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 NUP188 TAF1 SPEN EP300 AFF4 | 1.13e-06 | 1118 | 51 | 27 | HP:0000277 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 TAF1 SPEN EP300 AFF4 | 1.57e-06 | 915 | 51 | 24 | HP:0009116 |
| HumanPheno | Abnormality of the jaws | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR JARID2 SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 NUP188 TAF1 SPEN EP300 AFF4 | 3.15e-06 | 1175 | 51 | 27 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR JARID2 SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 NUP188 TAF1 SPEN EP300 AFF4 | 3.21e-06 | 1176 | 51 | 27 | HP:0030791 |
| HumanPheno | Narrow palate | 3.43e-06 | 202 | 51 | 11 | HP:0000189 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 TAF1 SPEN EP300 AFF4 | 9.31e-06 | 1008 | 51 | 24 | HP:0009122 |
| HumanPheno | Abnormality of calvarial morphology | STAC3 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 SERPINH1 ADAR HNRNPU GHR JARID2 BRCA1 SETD5 BRPF1 SCN8A ANKRD11 PLAGL1 CHD6 NUP188 TAF1 EML1 SPEN EP300 AFF4 | 2.17e-05 | 1134 | 51 | 25 | HP:0002648 |
| HumanPheno | Facial hypertrichosis | AFF3 HNRNPU MAPK8IP3 JARID2 SETD5 ANKRD11 TAF1 SPEN EP300 AFF4 | 2.81e-05 | 206 | 51 | 10 | HP:0002219 |
| HumanPheno | Abnormality of upper lip vermillion | AFF3 TRPS1 APC HNRNPU MAPK8IP3 JARID2 SNIP1 BRCA1 SETD5 ANKRD11 CDK5RAP2 TAF1 SPEN EP300 AFF4 | 2.87e-05 | 464 | 51 | 15 | HP:0011339 |
| HumanPheno | Abnormal calvaria morphology | STAC3 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 KLHL41 SERPINH1 ADAR HNRNPU GHR JARID2 BRCA1 SETD5 BRPF1 SCN8A ANKRD11 PLAGL1 CHD6 NUP188 TAF1 EML1 SPEN EP300 AFF4 | 4.06e-05 | 1254 | 51 | 26 | HP:0002683 |
| HumanPheno | Abnormality of the scalp hair | TRPS1 NSD1 APC UBA2 SALL4 JARID2 BRCA1 AEBP1 SETD5 H1-4 ANKRD11 SPEN USP48 EP300 | 5.72e-05 | 433 | 51 | 14 | HP:0100037 |
| HumanPheno | Abnormal scalp morphology | TRPS1 NSD1 APC UBA2 SALL4 JARID2 BRCA1 AEBP1 SETD5 H1-4 ANKRD11 SPEN USP48 EP300 | 8.74e-05 | 450 | 51 | 14 | HP:0001965 |
| HumanPheno | Thin upper lip vermilion | AFF3 TRPS1 APC MAPK8IP3 BRCA1 SETD5 ANKRD11 CDK5RAP2 TAF1 SPEN EP300 AFF4 | 9.25e-05 | 339 | 51 | 12 | HP:0000219 |
| HumanPheno | Thin lips | AFF3 TRPS1 APC MAPK8IP3 BRCA1 SETD5 ANKRD11 CDK5RAP2 TAF1 SPEN EP300 AFF4 | 9.25e-05 | 339 | 51 | 12 | HP:0000213 |
| HumanPheno | Synophrys | 1.11e-04 | 195 | 51 | 9 | HP:0000664 | |
| HumanPheno | Abnormality of the hairline | NSD1 APC SALL4 JARID2 BRCA1 AEBP1 SETD5 H1-4 ANKRD11 SPEN EP300 | 1.17e-04 | 294 | 51 | 11 | HP:0009553 |
| HumanPheno | Thick eyebrow | 1.23e-04 | 154 | 51 | 8 | HP:0000574 | |
| HumanPheno | High palate | STAC3 TRPS1 NSD1 APC KLHL41 HNRNPU MAPK8IP3 SNIP1 DST BRCA1 AEBP1 ANKRD11 PLAGL1 CHD6 NUP188 TAF1 SPEN EP300 AFF4 | 1.26e-04 | 794 | 51 | 19 | HP:0000218 |
| HumanPheno | Abnormality of the outer ear | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 KLHL41 ADAR HNRNPU MAPK8IP3 JARID2 DST BRCA1 AEBP1 SETD5 BRPF1 ANKRD11 PLAGL1 NUP188 TAF1 SPEN EP300 AFF4 | 1.31e-04 | 1337 | 51 | 26 | HP:0000356 |
| HumanPheno | Abnormal size of the palpebral fissures | STAC3 AFF3 BAZ1B SALL4 MAPK8IP3 BRCA1 SETD5 BRPF1 ANKRD11 SPEN EP300 | 1.32e-04 | 298 | 51 | 11 | HP:0200007 |
| HumanPheno | High, narrow palate | 1.34e-04 | 156 | 51 | 8 | HP:0002705 | |
| HumanPheno | Frontal bossing | TRPS1 NSD1 APC UBA2 BAZ1B SALL4 SERPINH1 HNRNPU GHR JARID2 BRCA1 SETD5 BRPF1 SCN8A ANKRD11 CHD6 SPEN EP300 | 1.62e-04 | 738 | 51 | 18 | HP:0002007 |
| HumanPheno | Abnormal shape of the frontal region | TRPS1 NSD1 APC UBA2 BAZ1B SALL4 SERPINH1 HNRNPU GHR JARID2 BRCA1 SETD5 BRPF1 SCN8A ANKRD11 CHD6 SPEN EP300 | 1.71e-04 | 741 | 51 | 18 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | TRPS1 NSD1 APC UBA2 BAZ1B SALL4 SERPINH1 HNRNPU GHR JARID2 BRCA1 SETD5 BRPF1 SCN8A ANKRD11 CHD6 SPEN EP300 | 1.74e-04 | 742 | 51 | 18 | HP:0430000 |
| HumanPheno | Abnormal hair pattern | AFF3 NSD1 APC SALL4 HNRNPU MAPK8IP3 JARID2 BRCA1 AEBP1 SETD5 H1-4 ANKRD11 TAF1 SPEN USP48 EP300 AFF4 | 1.83e-04 | 676 | 51 | 17 | HP:0010720 |
| HumanPheno | Abnormality of the forehead | RPGRIP1 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 SERPINH1 HNRNPU GHR JARID2 BRCA1 SETD5 BRPF1 SCN8A H1-4 ANKRD11 CDK5RAP2 CHD6 NUP188 TAF1 SPEN EP300 AFF4 | 2.11e-04 | 1208 | 51 | 24 | HP:0000290 |
| HumanPheno | Abnormal pinna morphology | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC UBA2 BAZ1B SALL4 KLHL41 ADAR MAPK8IP3 JARID2 DST BRCA1 AEBP1 SETD5 BRPF1 ANKRD11 PLAGL1 NUP188 TAF1 SPEN EP300 AFF4 | 2.38e-04 | 1299 | 51 | 25 | HP:0000377 |
| HumanPheno | Thin vermilion border | AFF3 TRPS1 APC HNRNPU MAPK8IP3 BRCA1 SETD5 ANKRD11 CDK5RAP2 TAF1 SPEN EP300 AFF4 | 2.39e-04 | 433 | 51 | 13 | HP:0000233 |
| HumanPheno | Cervical C2/C3 vertebral fusion | 2.52e-04 | 13 | 51 | 3 | HP:0004602 | |
| HumanPheno | Keloids | 2.52e-04 | 13 | 51 | 3 | HP:0010562 | |
| HumanPheno | Blepharophimosis | 2.60e-04 | 129 | 51 | 7 | HP:0000581 | |
| HumanPheno | Abnormal external nose morphology | RPGRIP1 AFF3 TRPS1 NSD1 APC SALL4 ADAR MAPK8IP3 GHR JARID2 SNIP1 BRCA1 SETD5 ANKRD11 CHD6 NUP188 TAF1 SPEN EP300 AFF4 | 2.80e-04 | 916 | 51 | 20 | HP:0010938 |
| HumanPheno | Abnormality of the tubular bones | RPGRIP1 AFF3 TRPS1 NSD1 APC BAZ1B SALL4 KLHL41 SERPINH1 MAPK8IP3 GHR SNIP1 BRCA1 SETD5 EP300 AFF4 | 2.82e-04 | 632 | 51 | 16 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | RPGRIP1 AFF3 TRPS1 NSD1 APC BAZ1B SALL4 KLHL41 SERPINH1 MAPK8IP3 GHR SNIP1 BRCA1 SETD5 EP300 AFF4 | 2.82e-04 | 632 | 51 | 16 | HP:0100714 |
| HumanPheno | Congenital abnormal hair pattern | NSD1 APC SALL4 JARID2 BRCA1 AEBP1 SETD5 H1-4 ANKRD11 SPEN EP300 | 3.00e-04 | 327 | 51 | 11 | HP:0011361 |
| HumanPheno | Abnormal midface morphology | RPGRIP1 STAC3 APC BAZ1B SALL4 SERPINH1 HNRNPU MAPK8IP3 GHR JARID2 AEBP1 H1-4 ANKRD11 CHD6 SPEN EP300 AFF4 | 3.01e-04 | 704 | 51 | 17 | HP:0000309 |
| HumanPheno | Medial flaring of the eyebrow | 3.61e-04 | 228 | 51 | 9 | HP:0010747 | |
| HumanPheno | Fused cervical vertebrae | 3.71e-04 | 35 | 51 | 4 | HP:0002949 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 APC BAZ1B SALL4 KLHL41 SERPINH1 HNRNPU MAPK8IP3 GHR NEFH SNIP1 BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 TAF1 SPEN EP300 AFF4 | 4.16e-04 | 1343 | 51 | 25 | HP:0009115 |
| HumanPheno | Abnormal location of ears | RPGRIP1 STAC3 AFF3 TRPS1 NSD1 UBA2 BAZ1B KLHL41 ADAR MAPK8IP3 JARID2 DST SETD5 BRPF1 ANKRD11 NUP188 TAF1 SPEN EP300 AFF4 | 4.31e-04 | 945 | 51 | 20 | HP:0000357 |
| HumanPheno | Abnormality of the palpebral fissures | STAC3 AFF3 NSD1 APC BAZ1B SALL4 HNRNPU MAPK8IP3 JARID2 BRCA1 SETD5 BRPF1 SCN8A ANKRD11 CDK5RAP2 TAF1 SPEN EP300 AFF4 | 5.01e-04 | 880 | 51 | 19 | HP:0008050 |
| HumanPheno | Abnormal palate morphology | RPGRIP1 STAC3 TRPS1 NSD1 APC SALL4 KLHL41 HNRNPU MAPK8IP3 JARID2 SNIP1 DST BRCA1 AEBP1 SETD5 ANKRD11 PLAGL1 CHD6 NUP188 TAF1 SPEN EP300 AFF4 | 5.67e-04 | 1202 | 51 | 23 | HP:0000174 |
| HumanPheno | Localized skin lesion | AFF3 APC UBA2 BAZ1B SALL4 ADAR HNRNPU GHR DST BRCA1 AEBP1 SETD5 H1-4 ANKRD11 CHD6 TAF1 SPEN USP48 EP300 | 6.42e-04 | 897 | 51 | 19 | HP:0011355 |
| HumanPheno | High forehead | 7.43e-04 | 306 | 51 | 10 | HP:0000348 | |
| HumanPheno | Vertebral fusion | 7.88e-04 | 74 | 51 | 5 | HP:0002948 | |
| HumanPheno | Abnormal hip joint morphology | AFF3 TRPS1 NSD1 APC UBA2 KLHL41 BRCA1 AEBP1 ANKRD11 TAF1 SPEN EP300 AFF4 | 7.97e-04 | 490 | 51 | 13 | HP:0001384 |
| HumanPheno | Long philtrum | TRPS1 NSD1 APC BAZ1B KLHL41 MAPK8IP3 SETD5 BRPF1 ANKRD11 TAF1 SPEN AFF4 | 8.31e-04 | 429 | 51 | 12 | HP:0000343 |
| HumanPheno | Deep philtrum | 8.38e-04 | 75 | 51 | 5 | HP:0002002 | |
| MousePheno | abnormal prenatal growth/weight/body size | ELOA STAC3 AFF3 APC BAZ1B SALL4 CBX4 DZIP1 ADAR HNRNPU PYHIN1 GHR CSDE1 INTS10 RSPO3 JARID2 DST BRCA1 SETD5 NFE2L1 SH3PXD2A PRRC2C ANKRD11 PLAGL1 ALAS1 PAK1IP1 REXO1L1P EP300 AFF4 RAD23B | 9.12e-06 | 1493 | 122 | 30 | MP:0004196 |
| MousePheno | abnormal prenatal body size | ELOA STAC3 AFF3 APC BAZ1B SALL4 CBX4 DZIP1 ADAR PYHIN1 GHR CSDE1 INTS10 RSPO3 JARID2 DST BRCA1 SETD5 NFE2L1 PRRC2C ANKRD11 PLAGL1 PAK1IP1 REXO1L1P EP300 | 9.72e-06 | 1116 | 122 | 25 | MP:0010866 |
| MousePheno | arrest of spermatogenesis | ZCWPW1 MAP2 BRCA1 ARID5B RBM5 MEIOSIN SPAG17 AFF4 MAJIN RAD23B | 4.57e-05 | 239 | 122 | 10 | MP:0001155 |
| Domain | Bromodomain_CS | 4.70e-08 | 26 | 149 | 6 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 4.42e-07 | 37 | 149 | 6 | PS00633 | |
| Domain | Bromodomain | 5.21e-07 | 38 | 149 | 6 | PF00439 | |
| Domain | BROMODOMAIN_2 | 8.32e-07 | 41 | 149 | 6 | PS50014 | |
| Domain | Bromodomain | 9.65e-07 | 42 | 149 | 6 | IPR001487 | |
| Domain | BROMO | 9.65e-07 | 42 | 149 | 6 | SM00297 | |
| Domain | - | 9.65e-07 | 42 | 149 | 6 | 1.20.920.10 | |
| Domain | CH | 1.31e-05 | 65 | 149 | 6 | SM00033 | |
| Domain | CH | 2.01e-05 | 70 | 149 | 6 | PF00307 | |
| Domain | - | 2.18e-05 | 71 | 149 | 6 | 1.10.418.10 | |
| Domain | CH | 2.55e-05 | 73 | 149 | 6 | PS50021 | |
| Domain | CH-domain | 2.98e-05 | 75 | 149 | 6 | IPR001715 | |
| Domain | HMG_BOX_2 | 6.97e-05 | 54 | 149 | 5 | PS50118 | |
| Domain | H15 | 1.34e-04 | 13 | 149 | 3 | SM00526 | |
| Domain | Linker_histone | 1.34e-04 | 13 | 149 | 3 | PF00538 | |
| Domain | H15 | 1.34e-04 | 13 | 149 | 3 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 1.70e-04 | 14 | 149 | 3 | IPR005818 | |
| Domain | - | 2.11e-04 | 15 | 149 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 2.11e-04 | 15 | 149 | 3 | SM00501 | |
| Domain | ARID_dom | 2.11e-04 | 15 | 149 | 3 | IPR001606 | |
| Domain | ARID | 2.11e-04 | 15 | 149 | 3 | PS51011 | |
| Domain | ARID | 2.11e-04 | 15 | 149 | 3 | PF01388 | |
| Domain | TF_AF4/FMR2 | 3.75e-04 | 4 | 149 | 2 | IPR007797 | |
| Domain | AF-4 | 3.75e-04 | 4 | 149 | 2 | PF05110 | |
| Domain | PWWP | 5.13e-04 | 20 | 149 | 3 | SM00293 | |
| Domain | FerI | 6.22e-04 | 5 | 149 | 2 | SM01202 | |
| Domain | FerB | 6.22e-04 | 5 | 149 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 6.22e-04 | 5 | 149 | 2 | IPR012561 | |
| Domain | Ferlin_C | 6.22e-04 | 5 | 149 | 2 | PF16165 | |
| Domain | Ferlin_C | 6.22e-04 | 5 | 149 | 2 | IPR032362 | |
| Domain | FerIin_dom | 6.22e-04 | 5 | 149 | 2 | IPR012968 | |
| Domain | FerI | 6.22e-04 | 5 | 149 | 2 | PF08151 | |
| Domain | FerB | 6.22e-04 | 5 | 149 | 2 | PF08150 | |
| Domain | PWWP | 7.84e-04 | 23 | 149 | 3 | PF00855 | |
| Domain | PWWP_dom | 7.84e-04 | 23 | 149 | 3 | IPR000313 | |
| Domain | HMG_box | 8.41e-04 | 53 | 149 | 4 | PF00505 | |
| Domain | PWWP | 8.91e-04 | 24 | 149 | 3 | PS50812 | |
| Domain | HMG | 9.03e-04 | 54 | 149 | 4 | SM00398 | |
| Domain | GAR | 9.29e-04 | 6 | 149 | 2 | PS51460 | |
| Domain | HELP | 9.29e-04 | 6 | 149 | 2 | PF03451 | |
| Domain | GAS2 | 9.29e-04 | 6 | 149 | 2 | PF02187 | |
| Domain | - | 9.29e-04 | 6 | 149 | 2 | 3.30.920.20 | |
| Domain | HELP | 9.29e-04 | 6 | 149 | 2 | IPR005108 | |
| Domain | GAS_dom | 9.29e-04 | 6 | 149 | 2 | IPR003108 | |
| Domain | GAS2 | 9.29e-04 | 6 | 149 | 2 | SM00243 | |
| Domain | - | 9.67e-04 | 55 | 149 | 4 | 1.10.30.10 | |
| Domain | DUF3585 | 1.29e-03 | 7 | 149 | 2 | IPR022735 | |
| Domain | DUF3585 | 1.29e-03 | 7 | 149 | 2 | PF12130 | |
| Domain | Histone_H5 | 1.72e-03 | 8 | 149 | 2 | IPR005819 | |
| Domain | DUF1669 | 1.72e-03 | 8 | 149 | 2 | PF07894 | |
| Domain | DUF1669 | 1.72e-03 | 8 | 149 | 2 | IPR012461 | |
| Domain | HMG_box_dom | 1.81e-03 | 65 | 149 | 4 | IPR009071 | |
| Domain | Chromodomain-like | 2.08e-03 | 32 | 149 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 2.28e-03 | 33 | 149 | 3 | IPR000953 | |
| Domain | CHROMO | 2.28e-03 | 33 | 149 | 3 | SM00298 | |
| Domain | Na_channel_asu | 2.73e-03 | 10 | 149 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.73e-03 | 10 | 149 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.73e-03 | 10 | 149 | 2 | PF06512 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 9.54e-06 | 65 | 107 | 6 | M39682 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 8.90e-05 | 12 | 107 | 3 | MM14554 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.15e-04 | 13 | 107 | 3 | M1018 | |
| Pathway | PID_RB_1PATHWAY | 1.32e-04 | 65 | 107 | 5 | M279 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 KIF23 ATXN7L2 CEBPB ARID4B RBBP5 RSL1D1 SF3A1 PARP2 NSD1 BAZ1B HMGB1 SRPRA NCL BRD3 LRRC59 ZC3H18 CBX4 GPATCH8 RRBP1 ADAR HNRNPU INTS10 SNIP1 PBRM1 DST BBX BRCA1 SUB1 H1-2 ARID5B H1-4 SLTM ANKRD11 RBM5 MLLT1 CHD6 NUP188 SPEN TOP1 EP300 RAD23B | 7.32e-25 | 1294 | 153 | 42 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 ELOA KIF23 WAPL ARID4B RSL1D1 EML4 SF3A1 CAST NSD1 BAZ1B HMGB1 NCL LRRC59 ZC3H18 CBX4 RRBP1 ADAR HMGB1P1 HNRNPU CEP170 BBX BRCA1 SUB1 PRRC2C H1-2 SEC16A SLTM ANKRD11 MLLT1 BOD1L1 TAF1 SPEN TOP1 AFF4 | 2.26e-22 | 954 | 153 | 35 | 36373674 |
| Pubmed | CEBPB NUMBL RBBP5 ZNF652 PARP2 TRPS1 AAK1 NSD1 APC BAZ1B SRPRA BRD3 CBX4 GPATCH8 SERPINH1 AKAP8L METTL14 FAM83B CSDE1 INTS10 JARID2 SNIP1 AFAP1 PBRM1 DST BBX BRCA1 MICALL2 SETD5 ANKRD11 RBM5 MLLT1 ZFHX3 CHD6 PAK1IP1 SPEN IQGAP3 AFF4 RAD23B | 1.08e-19 | 1497 | 153 | 39 | 31527615 | |
| Pubmed | NOLC1 ELOA KIF23 WAPL CEBPB RBBP5 TRPS1 UBA2 BAZ1B HMGB1 NCL BRD3 LRRC59 ZC3H18 CBX4 GPATCH8 RRBP1 SERPINH1 ADAR METTL14 CSDE1 PBRM1 SUB1 H1-2 SLTM BOD1L1 TAF1 PAK1IP1 METTL16 USP48 TOP1 EP300 RAD23B | 1.60e-19 | 1014 | 153 | 33 | 32416067 | |
| Pubmed | CYLC1 NOLC1 EFCAB5 RPGRIP1 ELOA SCN11A MYH13 RSL1D1 FBF1 ABCC5 HMGB1 NCL BRD3 LRRC59 RRBP1 TTC3 C2orf78 PGK2 AKAP8L FER1L6 HNRNPU DST BBX BRCA1 SETD5 SH3PXD2A PRRC2C H1-2 H1-4 TENM1 RBM5 MLLT1 BOD1L1 CHD6 SPAG17 SPEN KIAA2012 TOP1 | 2.38e-19 | 1442 | 153 | 38 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA KIF23 WAPL ARID4B RBBP5 NSD1 BAZ1B BRD3 LRRC59 ZC3H18 CBX4 GPATCH8 PBRM1 BBX BRCA1 SUB1 BRPF1 ELF1 BOD1L1 CHD6 TAF1 SPEN USP48 TOP1 AFF4 RAD23B | 2.49e-18 | 608 | 153 | 26 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 ELOA PTTG1 KIF23 WAPL ARID4B RSL1D1 EML4 SF3A1 CAST AAK1 UBA2 BAZ1B NCL BRD3 ZC3H18 GPATCH8 RRBP1 AKAP8L MAPK8IP3 MICALL1 SUB1 BRPF1 SEC16A ELF1 PAK1IP1 SPEN | 8.51e-17 | 774 | 153 | 27 | 15302935 |
| Pubmed | DCAF1 NOLC1 TUT4 WAPL ATXN7L2 ARID4B FXR2 FBF1 TRPS1 BAZ1B BRD3 ZC3H18 CBX4 AKAP8L CEP170 INTS10 SNIP1 PBRM1 BRCA1 SETD5 BRPF1 H1-2 SEC16A H1-4 MLLT1 ZFHX3 NUP188 TAF1 TOP1 EP300 AFF4 | 1.93e-16 | 1116 | 153 | 31 | 31753913 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 ELOA KIF23 WAPL NUMBL RSL1D1 SF3A1 EGLN1 CAST AAK1 BAZ1B NCL LRRC59 RRBP1 ADAR HNRNPU CEP170 CSDE1 DST SUB1 PRRC2C SEC16A H1-4 BOD1L1 PALLD TOP1 AFF4 | 8.31e-15 | 934 | 153 | 27 | 33916271 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TUT4 FXR2 RSL1D1 EML4 EGLN1 CAST AAK1 APC SRPRA LRRC59 RRBP1 TTC3 ADAR MICALL1 CEP170 CSDE1 BRCA1 SH3PXD2A PRRC2C BRPF1 SPEN SMAP2 PALLD TOP1 | 1.58e-14 | 724 | 153 | 24 | 36232890 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 ELOA KIF23 FXR2 RSL1D1 SF3A1 PARP2 BAZ1B HMGB1 SRPRA NCL LRRC59 ZC3H18 RRBP1 SERPINH1 ADAR HNRNPU METTL14 FAM83B CEP170 CSDE1 AFAP1 DST FAM83F PRRC2C SLTM PAK1IP1 SPEN TOP1 IQGAP3 | 3.41e-14 | 1257 | 153 | 30 | 36526897 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 ELOA NUMBL MAP2 SF3A1 APC HMGB1 NCL BRD3 LRRC59 ZC3H18 CBX4 GPATCH8 ADAR AKAP8L HNRNPU CEP170 AFAP1 DST BBX SUB1 SLTM RBM5 CHD6 PAK1IP1 SPEN TOP1 AFF4 | 3.84e-14 | 1082 | 153 | 28 | 38697112 |
| Pubmed | ANK3 NUMBL SF3A1 EGLN1 AAK1 APC ABCC5 SRPRA LRRC59 ZC3H18 RRBP1 HNRNPU FAM83B MICALL1 CEP170 CSDE1 DST PRRC2C SEC16A H1-4 BOD1L1 PALLD TOP1 | 8.91e-14 | 708 | 153 | 23 | 39231216 | |
| Pubmed | NOLC1 TPP2 KIF23 FXR2 RSL1D1 SF3A1 NSD1 BAZ1B NCL ZC3H18 SERPINH1 CEP170 CSDE1 PBRM1 DST PRRC2C SEC16A H1-4 SLTM NUP188 SPEN TOP1 | 1.56e-13 | 653 | 153 | 22 | 22586326 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ELOA WAPL SF3A1 BAZ1B NCL LRRC59 ZC3H18 ADAR BBX SUB1 ZFHX3 BOD1L1 TAF1 SPEN TOP1 AFF4 | 1.70e-13 | 283 | 153 | 16 | 30585729 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 KIF23 ANK3 FXR2 RSL1D1 FBF1 NCL ZC3H18 GHR CEP170 SNIP1 OTOF PRRC2C SLTM SPEN PALLD TOP1 | 5.55e-13 | 361 | 153 | 17 | 26167880 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 WAPL FXR2 RSL1D1 SF3A1 PARP2 UBA2 BAZ1B HMGB1 SRPRA NCL LRRC59 RRBP1 SERPINH1 ADAR AKAP8L HNRNPU CSDE1 SNIP1 PBRM1 SUB1 EIF2B3 H1-2 SEC16A H1-4 CHD6 PAK1IP1 TOP1 RAB13 | 7.30e-13 | 1318 | 153 | 29 | 30463901 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 TUT4 FXR2 RSL1D1 SF3A1 HMGB1 NCL ZC3H18 GPATCH8 RRBP1 ADAR AKAP8L HNRNPU CSDE1 SUB1 PRRC2C H1-2 H1-4 SLTM RBM5 METTL16 SPEN TOP1 | 1.32e-12 | 807 | 153 | 23 | 22681889 |
| Pubmed | NOLC1 KIF23 MYH13 ANK3 RSL1D1 EGLN1 APC ABCC5 SRPRA NCL FAM83B DST BBX BRCA1 CD99 SEC16A H1-4 RBM5 CDK5RAP2 ZFHX3 SPEN SMAP2 | 4.82e-12 | 777 | 153 | 22 | 35844135 | |
| Pubmed | NOLC1 KIF23 ATXN7L2 ARID4B RBBP5 RSL1D1 TRPS1 BAZ1B HMGB1 LRRC59 ZC3H18 GPATCH8 AKAP8L PBRM1 DST BBX BRCA1 PRRC2C ARID5B SEC16A MLLT1 ELF1 ZFHX3 CHD6 TAF1 SPEN SMAP2 TOP1 EP300 | 5.25e-12 | 1429 | 153 | 29 | 35140242 | |
| Pubmed | NOLC1 RBBP5 PARP2 BAZ1B NCL BRD3 ZC3H18 SNIP1 SUB1 PRRC2C RBM5 BOD1L1 SPEN TOP1 | 7.10e-12 | 251 | 153 | 14 | 31076518 | |
| Pubmed | ELOA FXR2 RSL1D1 NCL LRRC59 ZC3H18 GPATCH8 ADAR AKAP8L HNRNPU CEP170 CSDE1 SNIP1 BBX IGHG1 PRRC2C H1-2 SLTM PAK1IP1 METTL16 TOP1 | 7.37e-12 | 713 | 153 | 21 | 29802200 | |
| Pubmed | KIF23 ARID4B RSL1D1 PARP2 BRD3 CBX4 SERPINH1 MOB2 CEP170 PBRM1 DST BBX BRCA1 SEC16A SLTM CHD6 SPEN USP48 EP300 RAD23B | 9.66e-12 | 645 | 153 | 20 | 25281560 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 NOLC1 ELOA KIF23 WAPL RSL1D1 SF3A1 PARP2 BAZ1B SRPRA NCL GPATCH8 SERPINH1 ADAR AKAP8L HNRNPU H1-2 SLTM RBM5 BOD1L1 PAK1IP1 TOP1 AFF4 RAD23B | 1.19e-11 | 989 | 153 | 24 | 36424410 |
| Pubmed | NOLC1 WAPL ANK3 GAS2L3 RSL1D1 ZNF652 CAST AKNAD1 NSD1 APC BAZ1B SALL4 GPATCH8 TTC3 METTL14 SETD5 NFE2L1 ARID5B SEC16A SLTM CDK5RAP2 BOD1L1 ANKRD12 NUP188 AFF4 | 1.26e-11 | 1084 | 153 | 25 | 11544199 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | KIF23 WAPL FXR2 RBBP5 RSL1D1 APC NCL GPATCH8 RRBP1 SERPINH1 ADAR AKAP8L CEP170 PBRM1 SEC16A NUP188 PAK1IP1 | 1.28e-11 | 440 | 153 | 17 | 34244565 |
| Pubmed | 2.19e-11 | 45 | 153 | 8 | 33596420 | ||
| Pubmed | RBBP5 TRPS1 NSD1 BAZ1B NCL TTC3 ADAR DST SETD5 NFE2L1 PRRC2C BRPF1 SEC16A ANKRD11 EP300 | 2.46e-11 | 332 | 153 | 15 | 37433992 | |
| Pubmed | KIF23 WAPL FXR2 RBBP5 RSL1D1 SF3A1 BAZ1B NCL BRD3 LRRC59 ZC3H18 ADAR AKAP8L HNRNPU PBRM1 BRPF1 H1-4 SLTM RBM5 PAK1IP1 TOP1 RAD23B | 2.55e-11 | 847 | 153 | 22 | 35850772 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 ELOA FXR2 RSL1D1 SF3A1 BAZ1B NCL LRRC59 ZC3H18 ADAR AKAP8L HNRNPU PBRM1 PRRC2C H1-2 RBM5 ZFHX3 SPEN TOP1 | 2.67e-11 | 605 | 153 | 19 | 28977666 |
| Pubmed | NOLC1 RSL1D1 BAZ1B BRD3 ZC3H18 GPATCH8 PBRM1 ZFHX3 SPEN TOP1 | 3.35e-11 | 103 | 153 | 10 | 32744500 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 KIF23 FXR2 RSL1D1 SF3A1 PARP2 NCL LRRC59 CBX4 RRBP1 SERPINH1 ADAR HNRNPU CSDE1 SNIP1 DST IGHG1 H1-2 H1-4 SLTM PAK1IP1 TOP1 RAB13 | 3.42e-11 | 949 | 153 | 23 | 36574265 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 KIF23 NUMBL MAP2 AAK1 APC CBX4 DZIP1 SERPINH1 FAM83B MOB2 MICALL1 CEP170 DST SUB1 SH3PXD2A PRRC2C SEC16A ANKRD11 BOD1L1 SMAP2 PALLD | 3.49e-11 | 861 | 153 | 22 | 36931259 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 NOLC1 PTTG1 KIF23 WAPL RSL1D1 SF3A1 TRPS1 APC HMGB1 RRBP1 AKAP8L HNRNPU FAM83B MOB2 BCLAF3 CEP170 CSDE1 PBRM1 MICALL2 SUB1 CDK5RAP2 NUP188 IQGAP3 RAD23B | 4.84e-11 | 1155 | 153 | 25 | 20360068 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | NOLC1 ELOA RSL1D1 SF3A1 BAZ1B NCL ZC3H18 ADAR HNRNPU SLTM AFF4 | 6.33e-11 | 148 | 153 | 11 | 32538781 |
| Pubmed | TPP2 KIF23 FXR2 RSL1D1 APC HMGB1 NCL LRRC59 RRBP1 SERPINH1 ADAR HNRNPU CEP170 CSDE1 AFAP1 DST IGHG1 PRRC2C H1-2 H1-4 SLTM BOD1L1 NUP188 PALLD TOP1 RAB13 | 1.00e-10 | 1297 | 153 | 26 | 33545068 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 KIF23 WAPL RBBP5 RSL1D1 SF3A1 BAZ1B HMGB1 NCL LRRC59 RRBP1 TTC3 SERPINH1 ADAR HNRNPU JARID2 PBRM1 H1-2 SLTM RBM5 BOD1L1 NUP188 PAK1IP1 SPEN TOP1 IQGAP3 RAD23B | 1.46e-10 | 1425 | 153 | 27 | 30948266 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 ELOA KIF23 ARID4B FXR2 RSL1D1 BAZ1B NCL RRBP1 ADAR AKAP8L HNRNPU CEP170 CSDE1 PBRM1 PRRC2C H1-4 PAK1IP1 TOP1 IQGAP3 | 1.72e-10 | 759 | 153 | 20 | 35915203 |
| Pubmed | KIF23 WAPL NCL ADAR HNRNPU PBRM1 IGHG1 ANKRD11 RBM5 MLLT1 BOD1L1 KIAA2012 PALLD | 2.78e-10 | 272 | 153 | 13 | 31010829 | |
| Pubmed | ELOA MYH13 GAS2L3 FXR2 RSL1D1 EML4 SF3A1 AAK1 SRPRA NCL LRRC59 RRBP1 AKAP8L CEP170 CSDE1 SNIP1 PBRM1 PRRC2C RALBP1 SEC16A RBM5 PAK1IP1 TOP1 AFF4 MAJIN RAD23B | 3.28e-10 | 1371 | 153 | 26 | 36244648 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TUT4 ANK3 NUMBL MAP2 AFF3 TRPS1 CAST AAK1 RRBP1 TTC3 HNRNPU MAPK8IP3 CEP170 CSDE1 HIVEP3 SETD5 CD99 SH3PXD2A ARID5B ANKRD11 RBM5 ZFHX3 BOD1L1 CHD6 ANKRD12 EP300 AFF4 | 3.83e-10 | 1489 | 153 | 27 | 28611215 |
| Pubmed | KIF23 WAPL ANK3 CAST NSD1 BAZ1B ADAR CEP170 CSDE1 SUB1 PRRC2C SEC16A BOD1L1 TAF1 SPEN PALLD EP300 | 3.91e-10 | 549 | 153 | 17 | 38280479 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ANK3 HMGB1 NCL LRRC59 RRBP1 SERPINH1 HNRNPU HIVEP3 DST BRPF1 H1-2 SCN8A H1-4 SLTM PCNX1 ZFHX3 EML1 SPAG17 TOP1 IQGAP3 | 4.98e-10 | 807 | 153 | 20 | 30575818 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | FXR2 RSL1D1 PARP2 SRPRA NCL LRRC59 GPATCH8 RRBP1 AKAP8L HNRNPU CEP170 PBRM1 PRRC2C H1-2 TOP1 IQGAP3 | 5.48e-10 | 486 | 153 | 16 | 30940648 |
| Pubmed | NOLC1 FXR2 RSL1D1 SF3A1 NCL LRRC59 ZC3H18 ADAR AKAP8L HNRNPU SNIP1 SUB1 PRRC2C H1-2 H1-4 SLTM PAK1IP1 SPEN TOP1 | 6.39e-10 | 731 | 153 | 19 | 29298432 | |
| Pubmed | WAPL RBBP5 EML4 APC SRPRA NCL RRBP1 AKAP8L HNRNPU CSDE1 DST PRRC2C H1-4 SLTM TNFAIP2 METTL16 PALLD IQGAP3 | 6.87e-10 | 650 | 153 | 18 | 38777146 | |
| Pubmed | NOLC1 FXR2 RSL1D1 TRPS1 NCL LRRC59 ZC3H18 RRBP1 AKAP8L HNRNPU FAM83B CSDE1 BBX PRRC2C H1-2 SEC16A H1-4 CHD6 | 7.75e-10 | 655 | 153 | 18 | 35819319 | |
| Pubmed | DCAF1 ELOA AAK1 APC UBA2 RRBP1 SERPINH1 AKAP8L HNRNPU CEP170 CSDE1 DST PRRC2C SEC16A | 8.24e-10 | 360 | 153 | 14 | 33111431 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 GAS2L3 RSL1D1 SF3A1 BAZ1B NCL LRRC59 RRBP1 SERPINH1 ADAR HNRNPU FAM83B CEP170 PBRM1 DST IGHG1 SEC16A H1-4 SLTM NUP188 SPEN TOP1 | 9.08e-10 | 1024 | 153 | 22 | 24711643 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ANK3 FXR2 RSL1D1 SF3A1 CAST UBA2 HMGB1 NCL LRRC59 SERPINH1 ADAR AKAP8L HNRNPU CEP170 DST SUB1 PRRC2C EIF2B3 H1-2 SEC16A TOP1 IQGAP3 RAD23B | 1.40e-09 | 1149 | 153 | 23 | 35446349 |
| Pubmed | TPP2 KIF23 ANK3 NUMBL FXR2 AAK1 NSD1 APC NCL TTC3 HNRNPU MAPK8IP3 CEP170 NEFH PBRM1 DST PRRC2C SEC16A CDK5RAP2 EML1 AFF4 | 1.75e-09 | 963 | 153 | 21 | 28671696 | |
| Pubmed | DCAF1 TPP2 RBBP5 RSL1D1 SALL4 GPATCH8 SERPINH1 AKAP8L JARID2 PBRM1 SPEN TOP1 RAB13 RAD23B | 2.80e-09 | 396 | 153 | 14 | 26687479 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | GAS2L3 FXR2 RSL1D1 NCL LRRC59 RRBP1 SERPINH1 ADAR HNRNPU CEP170 CSDE1 IGHG1 H1-2 SEC16A H1-4 TOP1 RAB13 | 2.82e-09 | 626 | 153 | 17 | 33644029 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | KIF23 WAPL SF3A1 CAST UBA2 NCL GPATCH8 HNRNPU PBRM1 BOD1L1 TAF1 USP48 PALLD | 3.12e-09 | 332 | 153 | 13 | 32786267 |
| Pubmed | DCAF1 TPP2 ANK3 FXR2 RSL1D1 ZC3H18 GPATCH8 RRBP1 FAM83B CEP170 JARID2 DST BRCA1 IGHG1 NUP188 PAK1IP1 RAD23B | 3.41e-09 | 634 | 153 | 17 | 34591612 | |
| Pubmed | NOLC1 TPP2 CEBPB RSL1D1 ZNF652 SF3A1 UBA2 HMGB1 ADAR HNRNPU CEP170 CSDE1 BRCA1 SUB1 PRRC2C H1-2 RBM5 ELF1 SPEN TOP1 EP300 RAD23B | 3.54e-09 | 1103 | 153 | 22 | 34189442 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | NOLC1 MYH13 EML4 SF3A1 AFF3 AAK1 GPATCH8 RRBP1 SERPINH1 CEP170 DST SH3PXD2A RALBP1 MLLT1 CDK5RAP2 NUP188 PALLD EP300 AFF4 RAD23B | 3.86e-09 | 910 | 153 | 20 | 36736316 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 NOLC1 KIF23 WAPL RSL1D1 EML4 AAK1 BAZ1B NCL RRBP1 SERPINH1 ADAR AKAP8L HNRNPU CSDE1 DST IGHG1 EIF2B3 H1-2 SEC16A SLTM PALLD TOP1 RAB13 | 6.27e-09 | 1353 | 153 | 24 | 29467282 |
| Pubmed | NOLC1 TUT4 ANK3 MAP2 FXR2 TCEAL5 AAK1 APC SRPRA NCL LRRC59 RRBP1 AKAP8L HNRNPU MAPK8IP3 CEP170 CSDE1 PRRC2C H1-2 H1-4 TENM1 NAV3 | 6.32e-09 | 1139 | 153 | 22 | 36417873 | |
| Pubmed | EFCAB5 MYH13 RSL1D1 NSD1 ADAR FER1L6 PBRM1 DST OTOF IGHG1 BRPF1 | 8.15e-09 | 234 | 153 | 11 | 36243803 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | NOLC1 AFF3 ZC3H18 AKAP8L FAM83B DST PRRC2C H1-2 SEC16A MLLT1 CDK5RAP2 TOP1 EP300 AFF4 | 8.43e-09 | 432 | 153 | 14 | 23455922 |
| Pubmed | WAPL ANK3 RSL1D1 TRPS1 APC ABCC5 DZIP1 RRBP1 TTC3 AKAP8L MAPK8IP3 CSDE1 DST OTOF RALBP1 ARID5B NAV3 CHD6 TAF1 TOP1 EP300 AFF4 RAD23B | 1.14e-08 | 1285 | 153 | 23 | 35914814 | |
| Pubmed | ARID4B FXR2 RSL1D1 SF3A1 CAST BAZ1B SRPRA NCL LRRC59 ZC3H18 RRBP1 SERPINH1 AKAP8L HNRNPU CSDE1 SNIP1 PRRC2C TENM1 TOP1 IQGAP3 | 1.14e-08 | 971 | 153 | 20 | 33306668 | |
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 1.43e-08 | 191 | 153 | 10 | 21907836 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.56e-08 | 203 | 153 | 10 | 22083510 | |
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 2.60e-08 | 41 | 153 | 6 | 20431927 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | NOLC1 FXR2 RSL1D1 SF3A1 BAZ1B LRRC59 ZC3H18 AKAP8L PBRM1 H1-2 H1-4 TOP1 | 2.92e-08 | 330 | 153 | 12 | 33301849 |
| Pubmed | 3.54e-08 | 157 | 153 | 9 | 30186101 | ||
| Pubmed | 3.95e-08 | 159 | 153 | 9 | 22751105 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPP2 MYH13 RSL1D1 SF3A1 UBA2 HMGB1 NCL ADAR PGK2 HMGB1P1 HNRNPU CSDE1 PBRM1 PRRC2C H1-2 H1-4 BOD1L1 TOP1 | 4.09e-08 | 847 | 153 | 18 | 35235311 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 WAPL RSL1D1 SF3A1 TRPS1 BAZ1B ZC3H18 CBX4 NUP188 SPEN TOP1 AFF4 | 4.17e-08 | 341 | 153 | 12 | 32971831 |
| Pubmed | 4.29e-08 | 75 | 153 | 7 | 25593309 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPP2 MAP2 RSL1D1 AAK1 SRPRA NCL LRRC59 HNRNPU CEP170 PBRM1 DST SEC16A BOD1L1 TOP1 | 4.96e-08 | 498 | 153 | 14 | 36634849 |
| Pubmed | NOLC1 PTTG1 KIF23 RSL1D1 AAK1 APC NCL RRBP1 ADAR PBRM1 SEC16A ELF1 SPEN PALLD | 5.61e-08 | 503 | 153 | 14 | 16964243 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ARID4B RBBP5 TRPS1 BAZ1B AKAP8L PBRM1 ARID5B SEC16A ZFHX3 TAF1 SPEN EP300 | 5.72e-08 | 351 | 153 | 12 | 38297188 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 TPP2 FXR2 RSL1D1 EML4 SF3A1 CAST SRPRA NCL LRRC59 ZC3H18 RRBP1 SERPINH1 HNRNPU CEP170 CSDE1 SUB1 IGHG1 PRRC2C H1-2 SEC16A PALLD TOP1 | 6.60e-08 | 1415 | 153 | 23 | 28515276 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | ARID4B SF3A1 BAZ1B ADAR AKAP8L BBX ARID5B SEC16A ANKRD11 ANKRD12 TOP1 | 7.08e-08 | 289 | 153 | 11 | 23752268 |
| Pubmed | 7.84e-08 | 123 | 153 | 8 | 35583604 | ||
| Pubmed | EML4 SF3A1 NCL LRRC59 RRBP1 SERPINH1 ADAR HNRNPU PRRC2C H1-4 SLTM | 8.72e-08 | 295 | 153 | 11 | 26209609 | |
| Pubmed | NOLC1 FXR2 RSL1D1 EGLN1 NCL LRRC59 ADAR HNRNPU CEP170 CSDE1 H1-2 H1-4 TOP1 | 8.83e-08 | 441 | 153 | 13 | 31239290 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CEBPB NSD1 TTC3 MAPK8IP3 MICALL1 HIVEP3 DST FAM83F SETD5 EIF2B3 SCN8A SEC16A ANKRD11 MLLT1 PCNX1 TNFAIP2 NUP188 SPEN IQGAP3 EP300 | 9.44e-08 | 1105 | 153 | 20 | 35748872 |
| Pubmed | ZNF689 TRPS1 BAZ1B HMGB1 SALL4 BRD3 DZIP1 HIVEP3 JARID2 PBRM1 BBX NFE2L1 BRPF1 ARID5B SLTM ELF1 ZFHX3 | 1.15e-07 | 808 | 153 | 17 | 20412781 | |
| Pubmed | KIF23 RBBP5 SF3A1 HMGB1 SRPRA LRRC59 SERPINH1 ADAR AKAP8L MOB2 CEP170 CSDE1 SUB1 SH3PXD2A RALBP1 BRPF1 SEC16A RBM5 | 1.31e-07 | 916 | 153 | 18 | 32203420 | |
| Pubmed | NOLC1 KIF23 FXR2 SF3A1 APC HMGB1 NCL LRRC59 RRBP1 SERPINH1 AKAP8L HNRNPU FAM83B H1-2 SEC16A H1-4 MLLT1 TOP1 RAB13 AFF4 RAD23B | 1.46e-07 | 1247 | 153 | 21 | 27684187 | |
| Pubmed | 1.53e-07 | 90 | 153 | 7 | 23151878 | ||
| Pubmed | NOLC1 SALL4 BRD3 LRRC59 ZC3H18 JARID2 SNIP1 PBRM1 PRRC2C SLTM BOD1L1 CHD6 SPEN | 1.79e-07 | 469 | 153 | 13 | 27634302 | |
| Pubmed | NOLC1 EML4 HMGB1 NCL LRRC59 RRBP1 HNRNPU CD99 H1-2 H1-4 TOP1 | 1.79e-07 | 317 | 153 | 11 | 30997501 | |
| Pubmed | 1.90e-07 | 191 | 153 | 9 | 20195357 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | WAPL FXR2 RBBP5 PARP2 BRD3 ZC3H18 RRBP1 PBRM1 H1-2 TAF1 USP48 RAD23B | 1.99e-07 | 394 | 153 | 12 | 27248496 |
| Pubmed | NOLC1 ARID4B RSL1D1 BAZ1B RRBP1 ADAR PBRM1 PRRC2C BRPF1 PAK1IP1 | 2.00e-07 | 253 | 153 | 10 | 29911972 | |
| Pubmed | NOLC1 RSL1D1 SF3A1 BAZ1B NCL LRRC59 SERPINH1 ADAR HNRNPU BRCA1 IGHG1 H1-2 H1-4 SLTM TOP1 | 2.17e-07 | 652 | 153 | 15 | 31180492 | |
| Pubmed | NOLC1 ELOA RSL1D1 NCL RRBP1 ADAR AKAP8L PBRM1 PRRC2C H1-2 H1-4 PAK1IP1 TOP1 | 2.50e-07 | 483 | 153 | 13 | 36912080 | |
| Pubmed | DCAF1 GPATCH8 CSDE1 NEFH SETD5 PRRC2C SEC16A NAV3 BOD1L1 CHD6 ANKRD12 SPEN | 2.81e-07 | 407 | 153 | 12 | 12693553 | |
| Pubmed | NOLC1 TPP2 KIF23 RBBP5 SF3A1 NCL LRRC59 SERPINH1 HNRNPU CSDE1 BRCA1 SEC16A PALLD | 3.22e-07 | 494 | 153 | 13 | 26831064 | |
| Pubmed | RBBP5 RSL1D1 KLHL41 DZIP1 TTC3 CEP170 DST NFE2L1 RALBP1 RBM5 CDK5RAP2 TAF1 PALLD | 3.45e-07 | 497 | 153 | 13 | 23414517 | |
| Pubmed | NOLC1 TPP2 KIF23 FXR2 RBBP5 RSL1D1 PARP2 NAPG HMGB1 SRPRA LRRC59 SERPINH1 AKAP8L HNRNPU CEP170 CSDE1 AFAP1 DST SUB1 PRRC2C EIF2B3 NUP188 | 3.77e-07 | 1440 | 153 | 22 | 30833792 | |
| Pubmed | 4.73e-07 | 15 | 153 | 4 | 28784777 | ||
| Pubmed | DCAF1 NOLC1 ANK3 NUMBL MAP2 RSL1D1 SF3A1 BAZ1B SRPRA NCL LRRC59 DZIP1 RRBP1 TTC3 FAM83B MICALL1 CD99 ANKRD11 CDK5RAP2 ALAS1 USP48 SMAP2 | 6.45e-07 | 1487 | 153 | 22 | 33957083 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 6.50e-07 | 162 | 153 | 8 | 31363146 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NOLC1 KIF23 RSL1D1 SF3A1 AAK1 NAPG NCL LRRC59 ZC3H18 SERPINH1 ADAR HNRNPU CEP170 CSDE1 SUB1 H1-2 SEC16A SLTM PALLD RAB13 RAD23B | 6.53e-07 | 1367 | 153 | 21 | 32687490 |
| Interaction | H3C1 interactions | DCAF1 ELOA KIF23 WAPL ARID4B ANK3 RBBP5 RSL1D1 PARP2 EGLN1 CAST NSD1 BAZ1B HMGB1 BRD3 LRRC59 CBX4 RRBP1 HNRNPU PBRM1 BBX MICALL2 PRRC2C RALBP1 BRPF1 H1-2 H1-4 NAV3 MLLT1 ZFHX3 TAF1 SPEN USP48 PALLD TOP1 EP300 AFF4 RAD23B | 1.12e-18 | 901 | 150 | 38 | int:H3C1 |
| Interaction | H3-3A interactions | DCAF1 ELOA KIF23 WAPL ARID4B RBBP5 EML4 PARP2 NSD1 BAZ1B HMGB1 NCL BRD3 CBX4 GPATCH8 PBRM1 BBX BRCA1 SUB1 RALBP1 BRPF1 H1-2 H1-4 ELF1 BOD1L1 TAF1 SPEN USP48 TOP1 EP300 AFF4 RAD23B | 6.70e-16 | 749 | 150 | 32 | int:H3-3A |
| Interaction | SMC5 interactions | NOLC1 ELOA KIF23 WAPL ARID4B RSL1D1 EML4 SF3A1 CAST NSD1 UBA2 BAZ1B HMGB1 NCL LRRC59 ZC3H18 CBX4 RRBP1 ADAR HMGB1P1 HNRNPU CEP170 BBX BRCA1 SUB1 PRRC2C H1-2 SEC16A SLTM ANKRD11 MLLT1 BOD1L1 TAF1 SPEN TOP1 AFF4 | 1.57e-15 | 1000 | 150 | 36 | int:SMC5 |
| Interaction | CHD3 interactions | NOLC1 ELOA KIF23 ARID4B FXR2 RBBP5 RSL1D1 SF3A1 TRPS1 BAZ1B SALL4 NCL LRRC59 ZC3H18 CBX4 ADAR RGS2 AKAP8L HNRNPU PBRM1 PRRC2C H1-2 H1-4 RBM5 ZFHX3 CHD6 TAF1 TOP1 EP300 | 2.96e-13 | 757 | 150 | 29 | int:CHD3 |
| Interaction | PARP1 interactions | NOLC1 ELOA KIF23 CEBPB ARID4B RSL1D1 SF3A1 PARP2 NSD1 UBA2 BAZ1B HMGB1 NCL BRD3 ZC3H18 CBX4 SERPINH1 ADAR METTL14 PYHIN1 MICALL1 CEP170 PBRM1 BBX BRCA1 SUB1 H1-2 TENM1 MLLT1 CDK5RAP2 CHD6 NUP188 USP48 TOP1 IQGAP3 EP300 AFF4 | 1.20e-12 | 1316 | 150 | 37 | int:PARP1 |
| Interaction | DDX23 interactions | NOLC1 ELOA KIF23 CEBPB RSL1D1 SF3A1 HMGB1 NCL LRRC59 ZC3H18 GPATCH8 HNRNPU BRCA1 SUB1 BRPF1 SLTM ANKRD11 RBM5 MLLT1 TAF1 TOP1 EP300 AFF4 | 1.24e-12 | 480 | 150 | 23 | int:DDX23 |
| Interaction | RPS6 interactions | DCAF1 NOLC1 ELOA KIF23 CEBPB RSL1D1 ZNF689 HMGB1 NCL BRD3 LRRC59 ZC3H18 RRBP1 ADAR AKAP8L HNRNPU METTL14 PYHIN1 SNIP1 H1-8 BBX BRCA1 MICALL2 SUB1 H1-4 SLTM CHD6 NUP188 PAK1IP1 TOP1 | 1.80e-12 | 874 | 150 | 30 | int:RPS6 |
| Interaction | CHD4 interactions | NOLC1 ELOA KIF23 CEBPB FXR2 RSL1D1 EML4 SF3A1 TRPS1 BAZ1B SALL4 NCL BRD3 ZC3H18 GPATCH8 RRBP1 ADAR AKAP8L HNRNPU PYHIN1 SNIP1 PBRM1 SUB1 PRRC2C H1-2 H1-4 RBM5 ZFHX3 SPEN TOP1 EP300 | 1.93e-12 | 938 | 150 | 31 | int:CHD4 |
| Interaction | ZNF330 interactions | NOLC1 ELOA ARID4B RSL1D1 NSD1 BAZ1B HMGB1 NCL BRD3 ZC3H18 GPATCH8 PBRM1 BBX SUB1 BRPF1 ANKRD11 MLLT1 NUP188 TAF1 USP48 TOP1 AFF4 | 2.26e-12 | 446 | 150 | 22 | int:ZNF330 |
| Interaction | H2BC8 interactions | ELOA KIF23 WAPL ARID4B RBBP5 PARP2 NSD1 BAZ1B BRD3 CBX4 PBRM1 BBX BRCA1 SUB1 BRPF1 ARID5B SEC16A H1-4 ELF1 CHD6 SPEN USP48 TOP1 RAD23B | 7.41e-12 | 576 | 150 | 24 | int:H2BC8 |
| Interaction | RSL1D1 interactions | NOLC1 KIF23 CEBPB FXR2 RSL1D1 ZNF689 CAST NSD1 HMGB1 NCL LRRC59 ZC3H18 HNRNPU METTL14 PYHIN1 SNIP1 H1-8 DST BRCA1 SUB1 H1-2 H1-4 | 9.20e-12 | 479 | 150 | 22 | int:RSL1D1 |
| Interaction | H3C3 interactions | ELOA KIF23 WAPL RBBP5 NSD1 BAZ1B BRD3 LRRC59 ZC3H18 CBX4 PBRM1 BBX BRCA1 BRPF1 BOD1L1 CHD6 TAF1 SPEN USP48 TOP1 AFF4 RAD23B | 1.74e-11 | 495 | 150 | 22 | int:H3C3 |
| Interaction | RPL31 interactions | NOLC1 ELOA KIF23 CEBPB RSL1D1 ZNF689 NSD1 HMGB1 SRPRA NCL BRD3 LRRC59 ZC3H18 RRBP1 METTL14 SNIP1 BBX BRCA1 H1-2 H1-4 ANKRD11 NUP188 TAF1 PAK1IP1 TOP1 | 3.83e-11 | 680 | 150 | 25 | int:RPL31 |
| Interaction | SSRP1 interactions | NOLC1 ELOA KIF23 CEBPB RBBP5 RSL1D1 HMGB1 BRD3 ZC3H18 ADAR AKAP8L HNRNPU PYHIN1 CSDE1 INTS10 SNIP1 PBRM1 BRCA1 SETD5 SUB1 BRPF1 SLTM ANKRD11 TOP1 EP300 | 4.47e-11 | 685 | 150 | 25 | int:SSRP1 |
| Interaction | KCNA3 interactions | ANK3 NUMBL SF3A1 EGLN1 AKNAD1 AAK1 APC ABCC5 SRPRA LRRC59 ZC3H18 RRBP1 SERPINH1 HNRNPU FAM83B MICALL1 CEP170 CSDE1 DST PRRC2C SEC16A H1-4 CDK5RAP2 BOD1L1 SPEN PALLD TOP1 IQGAP3 | 5.11e-11 | 871 | 150 | 28 | int:KCNA3 |
| Interaction | H2BC9 interactions | CYLC1 RSL1D1 FBF1 NSD1 BAZ1B HMGB1 GPATCH8 RRBP1 SNIP1 H1-8 DST OTOF SUB1 IGHG1 H1-2 H1-4 RBM5 SPAG17 PALLD AFF4 | 1.34e-10 | 446 | 150 | 20 | int:H2BC9 |
| Interaction | COIL interactions | NOLC1 ELOA KIF23 FXR2 RSL1D1 SF3A1 NSD1 HMGB1 BRD3 ZC3H18 CBX4 SERPINH1 PBRM1 BBX BRPF1 ANKRD11 MLLT1 CHD6 NUP188 TAF1 TOP1 AFF4 | 1.41e-10 | 552 | 150 | 22 | int:COIL |
| Interaction | NAA40 interactions | NOLC1 TPP2 ELOA KIF23 WAPL NUMBL RSL1D1 SF3A1 PARP2 EGLN1 CAST AAK1 BAZ1B NCL LRRC59 RRBP1 ADAR HNRNPU CEP170 CSDE1 DST SUB1 PRRC2C SEC16A H1-4 BOD1L1 PALLD TOP1 AFF4 | 1.49e-10 | 978 | 150 | 29 | int:NAA40 |
| Interaction | MACROH2A1 interactions | DCAF1 KIF23 CEBPB EML4 HMGB1 NCL BRD3 ZC3H18 AKAP8L HNRNPU METTL14 PYHIN1 SNIP1 PBRM1 BRCA1 MICALL2 H1-2 H1-4 USP48 TOP1 | 2.14e-10 | 458 | 150 | 20 | int:MACROH2A1 |
| Interaction | MECP2 interactions | NOLC1 ELOA NUMBL MAP2 FXR2 RBBP5 SF3A1 NSD1 APC HMGB1 NCL BRD3 LRRC59 ZC3H18 CBX4 GPATCH8 ADAR AKAP8L HNRNPU PYHIN1 CEP170 AFAP1 DST BBX SUB1 SLTM RBM5 CHD6 PAK1IP1 SPEN TOP1 EP300 AFF4 | 2.86e-10 | 1287 | 150 | 33 | int:MECP2 |
| Interaction | H2AZ1 interactions | KIF23 CEBPB ARID4B RBBP5 PARP2 NSD1 BAZ1B HMGB1 BRD3 ZC3H18 METTL14 PYHIN1 PBRM1 H1-2 ARID5B USP48 TOP1 AFF4 | 3.42e-10 | 371 | 150 | 18 | int:H2AZ1 |
| Interaction | CSNK2A1 interactions | NOLC1 KIF23 ARID4B FXR2 RBBP5 RSL1D1 SF3A1 STAC3 APC HMGB1 NCL BRD3 LRRC59 ZC3H18 CBX4 METTL14 CEP170 DST BRCA1 SUB1 PRRC2C EIF2B3 ANKRD11 MLLT1 TAF1 USP48 TOP1 EP300 | 4.30e-10 | 956 | 150 | 28 | int:CSNK2A1 |
| Interaction | CENPA interactions | KIF23 PARP2 NSD1 BAZ1B HMGB1 BRD3 HNRNPU PBRM1 BBX BRPF1 H1-2 ANKRD11 MLLT1 CHD6 NUP188 TAF1 USP48 TOP1 | 4.43e-10 | 377 | 150 | 18 | int:CENPA |
| Interaction | RPL11 interactions | NOLC1 KIF23 WAPL CEBPB RSL1D1 ZNF689 UBA2 HMGB1 NCL LRRC59 ZC3H18 RRBP1 HNRNPU METTL14 SNIP1 PBRM1 BRCA1 SUB1 PRRC2C H1-2 H1-4 PAK1IP1 USP48 | 5.66e-10 | 652 | 150 | 23 | int:RPL11 |
| Interaction | POLR1G interactions | NOLC1 ELOA CEBPB ARID4B RSL1D1 NSD1 HMGB1 NCL BRD3 ZC3H18 PBRM1 BBX BRPF1 ANKRD11 MLLT1 NUP188 TAF1 USP48 TOP1 AFF4 | 6.71e-10 | 489 | 150 | 20 | int:POLR1G |
| Interaction | CSNK2A2 interactions | NOLC1 ELOA KIF23 TUT4 ARID4B FXR2 RBBP5 SF3A1 HMGB1 NCL BRD3 ZC3H18 CBX4 TTC3 PYHIN1 CEP170 IGHG1 PRRC2C BRPF1 H1-2 RBM5 TOP1 EP300 RAD23B | 6.74e-10 | 718 | 150 | 24 | int:CSNK2A2 |
| Interaction | SNRNP70 interactions | ELOA KIF23 CEBPB FXR2 RSL1D1 EML4 SF3A1 NCL LRRC59 ZC3H18 GPATCH8 ADAR AKAP8L HNRNPU METTL14 PYHIN1 CEP170 CSDE1 SNIP1 BBX IGHG1 PRRC2C H1-2 SLTM PAK1IP1 METTL16 TOP1 EP300 | 8.23e-10 | 984 | 150 | 28 | int:SNRNP70 |
| Interaction | SOX2 interactions | DCAF1 ELOA KIF23 CEBPB ARID4B GAS2L3 RBBP5 RSL1D1 TRPS1 NSD1 BAZ1B SALL4 NCL CBX4 TTC3 ADAR AKAP8L HNRNPU CEP170 PBRM1 ARID5B SEC16A SLTM NAV3 RBM5 MLLT1 ZFHX3 BOD1L1 CHD6 SPEN TOP1 IQGAP3 EP300 RAD23B | 9.04e-10 | 1422 | 150 | 34 | int:SOX2 |
| Interaction | XRCC6 interactions | ELOA PTTG1 KIF23 WAPL CEBPB SF3A1 PARP2 NSD1 BAZ1B NCL LRRC59 ZC3H18 ADAR RGS2 METTL14 PYHIN1 CSDE1 BBX BRCA1 SUB1 ZFHX3 BOD1L1 TAF1 SPEN TOP1 EP300 AFF4 | 1.07e-09 | 928 | 150 | 27 | int:XRCC6 |
| Interaction | NUP43 interactions | DCAF1 ARID4B RBBP5 RSL1D1 NSD1 APC ZC3H18 GPATCH8 PBRM1 DST BBX BRCA1 PRRC2C H1-2 H1-4 ANKRD11 ELF1 ZFHX3 BOD1L1 CHD6 SPEN TOP1 | 1.45e-09 | 625 | 150 | 22 | int:NUP43 |
| Interaction | NOP56 interactions | NOLC1 ELOA KIF23 CEBPB RSL1D1 NSD1 NCL BRD3 LRRC59 ZC3H18 SERPINH1 HNRNPU METTL14 BRCA1 SUB1 H1-4 ANKRD11 MLLT1 TOP1 EP300 AFF4 | 1.59e-09 | 570 | 150 | 21 | int:NOP56 |
| Interaction | SIRT6 interactions | KIF23 WAPL FXR2 RBBP5 RSL1D1 PARP2 APC NCL GPATCH8 RRBP1 SERPINH1 ADAR AKAP8L CEP170 PBRM1 SEC16A NUP188 PAK1IP1 USP48 PALLD IQGAP3 EP300 | 1.59e-09 | 628 | 150 | 22 | int:SIRT6 |
| Interaction | H1-5 interactions | EFCAB5 KIF23 CEBPB RSL1D1 PARP2 NSD1 ABCC5 HMGB1 NCL SERPINH1 HNRNPU PBRM1 MICALL2 H1-2 H1-4 RBM5 MLLT1 USP48 AFF4 | 1.76e-09 | 463 | 150 | 19 | int:H1-5 |
| Interaction | RPL6 interactions | DCAF1 NOLC1 KIF23 CEBPB RSL1D1 HMGB1 NCL LRRC59 ZC3H18 RRBP1 HNRNPU METTL14 PYHIN1 SNIP1 H1-8 DST BRCA1 MICALL2 H1-2 H1-4 PALLD TOP1 | 2.06e-09 | 637 | 150 | 22 | int:RPL6 |
| Interaction | RPL4 interactions | DCAF1 NOLC1 KIF23 CEBPB RSL1D1 NSD1 HMGB1 SRPRA NCL BRD3 LRRC59 ZC3H18 HNRNPU METTL14 PYHIN1 CSDE1 SNIP1 BBX BRCA1 MICALL2 H1-4 ANKRD11 PAK1IP1 SPEN | 2.31e-09 | 764 | 150 | 24 | int:RPL4 |
| Interaction | SUMO2 interactions | KIF23 WAPL CEBPB SF3A1 CAST UBA2 BAZ1B NCL BRD3 GPATCH8 HMGB1P1 HNRNPU PBRM1 DST BRCA1 BOD1L1 ALAS1 TAF1 USP48 PALLD EP300 | 3.01e-09 | 591 | 150 | 21 | int:SUMO2 |
| Interaction | DDX21 interactions | KIF23 CEBPB RSL1D1 ZNF689 APC BAZ1B NCL LRRC59 ZC3H18 ADAR AKAP8L HNRNPU METTL14 SNIP1 BRCA1 SUB1 PRRC2C H1-2 H1-4 SLTM RBM5 KIAA2012 TOP1 | 3.58e-09 | 718 | 150 | 23 | int:DDX21 |
| Interaction | NIFK interactions | NOLC1 ELOA KIF23 RBBP5 RSL1D1 ZNF689 NSD1 NCL BRD3 ZC3H18 ADAR NEFH BBX H1-4 ANKRD11 NUP188 PAK1IP1 AFF4 | 3.69e-09 | 431 | 150 | 18 | int:NIFK |
| Interaction | RPL10A interactions | KIF23 CEBPB HMGB1 SRPRA NCL LRRC59 ZC3H18 RRBP1 HNRNPU CSDE1 SNIP1 PBRM1 DST BRCA1 MICALL2 H1-4 PAK1IP1 SPEN USP48 | 4.45e-09 | 490 | 150 | 19 | int:RPL10A |
| Interaction | RPL23A interactions | DCAF1 NOLC1 KIF23 CEBPB MAP2 NSD1 HMGB1 NCL LRRC59 ZC3H18 CBX4 HNRNPU PYHIN1 SNIP1 DST BRCA1 MICALL2 H1-2 H1-4 PAK1IP1 TOP1 | 4.69e-09 | 606 | 150 | 21 | int:RPL23A |
| Interaction | TERF2IP interactions | ELOA KIF23 WAPL CEBPB NSD1 UBA2 HMGB1 ZC3H18 HNRNPU SNIP1 BBX BRCA1 ANKRD11 RBM5 BOD1L1 TAF1 SPEN USP48 TOP1 AFF4 | 5.34e-09 | 552 | 150 | 20 | int:TERF2IP |
| Interaction | RPL18A interactions | DCAF1 NOLC1 KIF23 CEBPB RSL1D1 ZNF689 HMGB1 NCL LRRC59 ZC3H18 ADAR HNRNPU METTL14 BBX BRCA1 MICALL2 SUB1 PAK1IP1 | 6.52e-09 | 447 | 150 | 18 | int:RPL18A |
| Interaction | SIRT7 interactions | DCAF1 NOLC1 TPP2 KIF23 FXR2 RSL1D1 SF3A1 NSD1 BAZ1B NCL ZC3H18 SERPINH1 CEP170 CSDE1 PBRM1 DST PRRC2C SEC16A H1-4 SLTM NUP188 SPEN TOP1 | 6.99e-09 | 744 | 150 | 23 | int:SIRT7 |
| Interaction | RPA4 interactions | WAPL FXR2 SF3A1 PARP2 APC NCL LRRC59 ZC3H18 CEP170 CSDE1 DST BRCA1 PRRC2C H1-2 SEC16A H1-4 SLTM PALLD | 7.75e-09 | 452 | 150 | 18 | int:RPA4 |
| Interaction | H2BC21 interactions | CYLC1 KIF23 ARID4B RBBP5 PARP2 NSD1 BAZ1B NCL ZC3H18 CBX4 HNRNPU PBRM1 BRCA1 OTOF SUB1 BRPF1 H1-2 H1-4 TENM1 MLLT1 TOP1 EP300 | 1.03e-08 | 696 | 150 | 22 | int:H2BC21 |
| Interaction | TMPO interactions | NOLC1 KIF23 WAPL CEBPB SRPRA NCL BRD3 LRRC59 ZC3H18 RRBP1 SERPINH1 ADAR AKAP8L HNRNPU METTL14 PYHIN1 SUB1 IGHG1 RALBP1 SEC16A H1-4 CDK5RAP2 EP300 | 1.09e-08 | 762 | 150 | 23 | int:TMPO |
| Interaction | BRD7 interactions | NOLC1 FXR2 RSL1D1 PARP2 SRPRA NCL BRD3 LRRC59 GPATCH8 RRBP1 AKAP8L HNRNPU CEP170 PBRM1 BRCA1 PRRC2C H1-2 ELF1 TOP1 IQGAP3 EP300 | 1.12e-08 | 637 | 150 | 21 | int:BRD7 |
| Interaction | POU5F1 interactions | DCAF1 TPP2 TUT4 WAPL RBBP5 RSL1D1 HMGB1 SALL4 NCL BRD3 SERPINH1 HNRNPU JARID2 PBRM1 H1-2 ZFHX3 TAF1 TOP1 RAB13 RAD23B | 1.37e-08 | 584 | 150 | 20 | int:POU5F1 |
| Interaction | NOP2 interactions | NOLC1 KIF23 CEBPB RSL1D1 HMGB1 ZC3H18 HNRNPU METTL14 SNIP1 H1-8 BBX BRCA1 H1-2 H1-4 PCNX1 TOP1 EP300 | 1.42e-08 | 416 | 150 | 17 | int:NOP2 |
| Interaction | NPM1 interactions | KIF23 CEBPB ANK3 FXR2 RSL1D1 PARP2 NSD1 BAZ1B HMGB1 NCL BRD3 LRRC59 ZC3H18 CBX4 DZIP1 RRBP1 ADAR HNRNPU METTL14 SNIP1 PBRM1 BRCA1 MICALL2 PRRC2C H1-2 H1-4 PAK1IP1 TOP1 EP300 | 1.60e-08 | 1201 | 150 | 29 | int:NPM1 |
| Interaction | H2AX interactions | KIF23 CEBPB ARID4B ZNF689 PARP2 BAZ1B NCL BRD3 ZC3H18 GPATCH8 METTL14 PYHIN1 PBRM1 BRCA1 H1-2 H1-4 MLLT1 USP48 EP300 RAD23B | 1.77e-08 | 593 | 150 | 20 | int:H2AX |
| Interaction | POLR2A interactions | ELOA CEBPB EGLN1 NSD1 BAZ1B HMGB1 NCL AKAP8L HNRNPU PYHIN1 INTS10 SNIP1 BRCA1 SUB1 RALBP1 H1-2 MLLT1 TOP1 EP300 | 1.89e-08 | 536 | 150 | 19 | int:POLR2A |
| Interaction | NOLC1 interactions | NOLC1 KIF23 CEBPB MYH13 RSL1D1 APC BRD3 ZC3H18 AKAP8L METTL14 SNIP1 BRCA1 SUB1 H1-4 AFF4 | 2.15e-08 | 325 | 150 | 15 | int:NOLC1 |
| Interaction | AATF interactions | NOLC1 KIF23 CEBPB FXR2 RSL1D1 NCL ADAR HNRNPU PYHIN1 CSDE1 SNIP1 BRCA1 PRRC2C H1-2 H1-4 SLTM | 2.22e-08 | 376 | 150 | 16 | int:AATF |
| Interaction | RSF1 interactions | 3.05e-08 | 124 | 150 | 10 | int:RSF1 | |
| Interaction | RPL7A interactions | DCAF1 NOLC1 KIF23 CEBPB RSL1D1 HMGB1 NCL LRRC59 ZC3H18 HNRNPU METTL14 PYHIN1 SNIP1 H1-8 BRCA1 MICALL2 SETD5 H1-4 PAK1IP1 USP48 TOP1 | 3.36e-08 | 679 | 150 | 21 | int:RPL7A |
| Interaction | ACTL6A interactions | CEBPB ARID4B SF3A1 UBA2 BAZ1B SALL4 NCL BRD3 ZC3H18 SNIP1 PBRM1 MLLT1 TOP1 EP300 | 3.56e-08 | 289 | 150 | 14 | int:ACTL6A |
| Interaction | NR2C2 interactions | DCAF1 NOLC1 WAPL FXR2 RSL1D1 SF3A1 PARP2 UBA2 BAZ1B HMGB1 SRPRA NCL LRRC59 RRBP1 SERPINH1 ADAR AKAP8L HNRNPU PYHIN1 CSDE1 SNIP1 PBRM1 SUB1 EIF2B3 H1-2 SEC16A H1-4 CHD6 PAK1IP1 TOP1 RAB13 | 3.64e-08 | 1403 | 150 | 31 | int:NR2C2 |
| Interaction | TERF2 interactions | TPP2 CEBPB FXR2 HMGB1 NCL BRD3 ZC3H18 GPATCH8 DST BRCA1 SUB1 SEC16A SLTM TOP1 EP300 | 3.90e-08 | 340 | 150 | 15 | int:TERF2 |
| Interaction | CDK9 interactions | KIF23 CEBPB EML4 SF3A1 AFF3 APC NCL LRRC59 CBX4 RRBP1 SERPINH1 ADAR HNRNPU BRCA1 PRRC2C H1-4 SLTM MLLT1 TOP1 EP300 AFF4 | 3.90e-08 | 685 | 150 | 21 | int:CDK9 |
| Interaction | GAPDH interactions | KIF23 CEBPB HMGB1 NCL ZC3H18 HNRNPU METTL14 CEP170 SNIP1 BRCA1 MICALL2 PRRC2C H1-2 SCN8A H1-4 SLTM RBM5 ZFHX3 USP48 EP300 AFF4 | 4.00e-08 | 686 | 150 | 21 | int:GAPDH |
| Interaction | H3-4 interactions | DCAF1 CEBPB RBBP5 PARP2 NSD1 NCL CBX4 HNRNPU PBRM1 PRRC2C RALBP1 H1-2 H1-4 MLLT1 CHD6 TAF1 EP300 | 4.20e-08 | 448 | 150 | 17 | int:H3-4 |
| Interaction | CSNK2B interactions | NOLC1 PTTG1 CEBPB FXR2 RBBP5 APC BRD3 LRRC59 ZC3H18 CBX4 PYHIN1 CEP170 AFAP1 BRCA1 SUB1 RALBP1 BRPF1 TENM1 ANKRD11 EP300 | 4.22e-08 | 625 | 150 | 20 | int:CSNK2B |
| Interaction | HNRNPA2B1 interactions | KIF23 CEBPB ARID4B SF3A1 CAST BAZ1B NCL ZC3H18 RRBP1 C2orf78 SERPINH1 HNRNPU METTL14 CSDE1 BRCA1 MICALL2 SEC16A ANKRD12 SPAG17 USP48 TOP1 EP300 | 4.30e-08 | 754 | 150 | 22 | int:HNRNPA2B1 |
| Interaction | ILF3 interactions | KIF23 CEBPB FXR2 RSL1D1 CAST NSD1 NCL LRRC59 ZC3H18 RRBP1 ADAR HNRNPU METTL14 SNIP1 BBX BRCA1 SUB1 PRRC2C H1-2 H1-4 RBM5 USP48 TOP1 EP300 | 4.92e-08 | 896 | 150 | 24 | int:ILF3 |
| Interaction | TOP1 interactions | DCAF1 KIF23 CEBPB ARID4B RBBP5 BAZ1B NCL BRD3 LRRC59 ZC3H18 CBX4 ADAR HNRNPU PBRM1 BRCA1 SUB1 RALBP1 BRPF1 H1-2 SLTM TOP1 | 5.12e-08 | 696 | 150 | 21 | int:TOP1 |
| Interaction | RAD18 interactions | NOLC1 ELOA RSL1D1 PARP2 UBA2 BAZ1B NCL BRD3 ZC3H18 SNIP1 AFAP1 BRCA1 SUB1 PRRC2C RBM5 SPEN TOP1 | 5.60e-08 | 457 | 150 | 17 | int:RAD18 |
| Interaction | SNRNP200 interactions | KIF23 WAPL CEBPB SF3A1 APC HMGB1 NCL LRRC59 ZC3H18 HNRNPU METTL14 SNIP1 BRCA1 RBM5 BOD1L1 TOP1 EP300 | 6.15e-08 | 460 | 150 | 17 | int:SNRNP200 |
| Interaction | SMARCA4 interactions | CEBPB ARID4B SF3A1 BAZ1B HMGB1 SALL4 NCL BRD3 RRBP1 TTC3 PYHIN1 SNIP1 PBRM1 BRCA1 MLLT1 TOP1 EP300 | 6.54e-08 | 462 | 150 | 17 | int:SMARCA4 |
| Interaction | TOP2A interactions | CYLC1 KIF23 CEBPB FXR2 RBBP5 BAZ1B HMGB1 BRD3 ZC3H18 ADAR HNRNPU METTL14 PYHIN1 PBRM1 BRCA1 PRRC2C TOP1 EP300 | 6.58e-08 | 520 | 150 | 18 | int:TOP2A |
| Interaction | HECTD1 interactions | NOLC1 ELOA KIF23 ARID4B FXR2 RSL1D1 APC BAZ1B NCL RRBP1 ADAR AKAP8L HNRNPU CEP170 CSDE1 PBRM1 SH3PXD2A PRRC2C H1-4 ANKRD11 TAF1 PAK1IP1 TOP1 IQGAP3 EP300 | 6.93e-08 | 984 | 150 | 25 | int:HECTD1 |
| Interaction | CIT interactions | NOLC1 KIF23 FXR2 RBBP5 RSL1D1 SF3A1 BAZ1B SRPRA NCL BRD3 LRRC59 TTC3 SERPINH1 ADAR AKAP8L HNRNPU PYHIN1 CEP170 BRCA1 SETD5 PRRC2C H1-2 H1-4 RBM5 CDK5RAP2 ELF1 BOD1L1 NUP188 SPAG17 TOP1 RAB13 | 7.67e-08 | 1450 | 150 | 31 | int:CIT |
| Interaction | SRPK2 interactions | NOLC1 ANK3 FXR2 RSL1D1 NCL BRD3 ZC3H18 GPATCH8 ADAR PYHIN1 GHR CEP170 SNIP1 OTOF PRRC2C H1-4 SLTM SPEN PALLD TOP1 EP300 | 8.45e-08 | 717 | 150 | 21 | int:SRPK2 |
| Interaction | RPS14 interactions | NOLC1 PTTG1 KIF23 CEBPB RSL1D1 HMGB1 NCL LRRC59 ZC3H18 ADAR HNRNPU METTL14 SNIP1 H1-8 BRCA1 MICALL2 USP48 TOP1 | 8.51e-08 | 529 | 150 | 18 | int:RPS14 |
| Interaction | H1-4 interactions | NOLC1 KIF23 CEBPB RBBP5 RSL1D1 NSD1 BAZ1B HMGB1 NCL LRRC59 ZC3H18 GPATCH8 PYHIN1 BBX RALBP1 H1-2 H1-4 PAK1IP1 SPAG17 USP48 | 9.28e-08 | 656 | 150 | 20 | int:H1-4 |
| Interaction | RPL3 interactions | DCAF1 KIF23 CEBPB RSL1D1 HMGB1 NCL LRRC59 ZC3H18 ADAR HNRNPU METTL14 SNIP1 H1-8 PBRM1 BRCA1 MICALL2 H1-2 H1-4 RBM5 PAK1IP1 USP48 | 9.49e-08 | 722 | 150 | 21 | int:RPL3 |
| Interaction | TOP2B interactions | KIF23 BAZ1B HMGB1 NCL BRD3 ADAR METTL14 PYHIN1 BRCA1 H1-4 MLLT1 TOP1 EP300 | 1.01e-07 | 266 | 150 | 13 | int:TOP2B |
| Interaction | HMGN2 interactions | CEBPB PARP2 STAC3 CAST BAZ1B BRD3 ZC3H18 H1-2 H1-4 CHD6 USP48 EP300 | 1.08e-07 | 222 | 150 | 12 | int:HMGN2 |
| Interaction | USP7 interactions | EFCAB5 KIF23 CEBPB MYH13 RSL1D1 FBF1 TCEAL5 TRPS1 NSD1 APC HMGB1 NCL CBX4 ADAR FER1L6 METTL14 PYHIN1 BCLAF3 PLA2R1 PBRM1 DST BRCA1 OTOF NFE2L1 IGHG1 BRPF1 TAF1 EP300 AFF4 | 1.10e-07 | 1313 | 150 | 29 | int:USP7 |
| Interaction | RPL8 interactions | KIF23 CEBPB RSL1D1 UBA2 HMGB1 NCL LRRC59 ZC3H18 CBX4 RRBP1 HNRNPU METTL14 PYHIN1 H1-8 BRCA1 MICALL2 H1-2 PAK1IP1 | 1.13e-07 | 539 | 150 | 18 | int:RPL8 |
| Interaction | DDX17 interactions | KIF23 CEBPB FXR2 SF3A1 NCL LRRC59 ZC3H18 ADAR HNRNPU METTL14 BRCA1 RBM5 SPEN USP48 TOP1 EP300 | 1.24e-07 | 426 | 150 | 16 | int:DDX17 |
| Interaction | DOT1L interactions | KIF23 WAPL FXR2 RSL1D1 SF3A1 BAZ1B NCL BRD3 LRRC59 ZC3H18 ADAR AKAP8L HNRNPU PBRM1 BRPF1 H1-2 H1-4 SLTM RBM5 MLLT1 PAK1IP1 RAD23B | 1.40e-07 | 807 | 150 | 22 | int:DOT1L |
| Interaction | ARID1A interactions | ARID4B RBBP5 BAZ1B SALL4 BRD3 TTC3 MAPK8IP3 SNIP1 PBRM1 BRCA1 MLLT1 TOP1 EP300 | 1.55e-07 | 276 | 150 | 13 | int:ARID1A |
| Interaction | YWHAH interactions | NOLC1 KIF23 CEBPB NUMBL MAP2 FXR2 AAK1 APC HMGB1 CBX4 DZIP1 SERPINH1 FAM83B PYHIN1 MICALL1 CEP170 DST SUB1 SH3PXD2A PRRC2C SEC16A ANKRD11 BOD1L1 USP48 SMAP2 PALLD | 1.57e-07 | 1102 | 150 | 26 | int:YWHAH |
| Interaction | FXR1 interactions | ELOA KIF23 TUT4 FXR2 AAK1 NCL LRRC59 TTC3 HNRNPU MAPK8IP3 CEP170 CSDE1 PRRC2C H1-2 SEC16A H1-4 MLLT1 ALAS1 EML1 EP300 | 1.62e-07 | 679 | 150 | 20 | int:FXR1 |
| Interaction | MEN1 interactions | NOLC1 KIF23 WAPL FXR2 RBBP5 RSL1D1 SF3A1 TRPS1 BAZ1B ZC3H18 CBX4 ADAR AKAP8L PBRM1 BRPF1 SLTM RBM5 BOD1L1 NUP188 TAF1 PAK1IP1 SPEN TOP1 AFF4 RAD23B | 1.62e-07 | 1029 | 150 | 25 | int:MEN1 |
| Interaction | HDAC1 interactions | DCAF1 NOLC1 CEBPB ARID4B RBBP5 EML4 SF3A1 PARP2 TRPS1 APC HMGB1 SRPRA SALL4 AKAP8L HNRNPU DST BBX BRCA1 RALBP1 ARID5B CDK5RAP2 PLAGL1 ZFHX3 TAF1 SPEN EP300 | 1.75e-07 | 1108 | 150 | 26 | int:HDAC1 |
| Interaction | KLF8 interactions | NOLC1 ARID4B TRPS1 BAZ1B HMGB1 LRRC59 AKAP8L MICALL1 PBRM1 PRRC2C SEC16A ELF1 SPEN EP300 | 1.76e-07 | 329 | 150 | 14 | int:KLF8 |
| Interaction | PRP4K interactions | KIF23 CEBPB RBBP5 SF3A1 BRD3 ZC3H18 CBX4 SNIP1 SUB1 H1-2 H1-4 SPEN TOP1 EP300 | 1.76e-07 | 329 | 150 | 14 | int:PRP4K |
| Interaction | MEX3A interactions | RBBP5 TRPS1 NSD1 BAZ1B NCL TTC3 ADAR DST SETD5 NFE2L1 PRRC2C BRPF1 SEC16A ANKRD11 EP300 | 1.90e-07 | 384 | 150 | 15 | int:MEX3A |
| Interaction | APEX1 interactions | NOLC1 ELOA KIF23 TUT4 WAPL CEBPB ARID4B RSL1D1 TRPS1 NSD1 BAZ1B NCL BRD3 TTC3 ADAR HNRNPU METTL14 PBRM1 BBX BRCA1 NFE2L1 H1-2 ANKRD11 PLAGL1 USP48 EP300 AFF4 RAD23B | 2.00e-07 | 1271 | 150 | 28 | int:APEX1 |
| Interaction | SUPT16H interactions | ELOA KIF23 CEBPB RBBP5 RSL1D1 SF3A1 BAZ1B HMGB1 BRD3 ZC3H18 HNRNPU PYHIN1 SNIP1 BRCA1 TOP1 EP300 | 2.04e-07 | 442 | 150 | 16 | int:SUPT16H |
| Interaction | PRC1 interactions | NOLC1 KIF23 FXR2 RSL1D1 SF3A1 APC BAZ1B NCL ZC3H18 SERPINH1 ADAR HNRNPU FAM83B AFAP1 PBRM1 BRCA1 H1-2 H1-4 SLTM CDK5RAP2 NUP188 SPEN TOP1 IQGAP3 | 2.26e-07 | 973 | 150 | 24 | int:PRC1 |
| Interaction | PRPF40A interactions | KIF23 CEBPB SF3A1 BRD3 ZC3H18 CBX4 DZIP1 AKAP8L HNRNPU SNIP1 H1-2 H1-4 ZFHX3 SPEN TOP1 EP300 | 2.30e-07 | 446 | 150 | 16 | int:PRPF40A |
| Interaction | CEBPB interactions | NOLC1 CEBPB RSL1D1 SF3A1 CAST UBA2 BAZ1B HMGB1 NCL LRRC59 GPATCH8 RRBP1 SERPINH1 ADAR AKAP8L HNRNPU CEP170 CSDE1 PBRM1 BRCA1 SUB1 CD99 PRRC2C EIF2B3 H1-2 H1-4 MLLT1 PALLD TOP1 EP300 | 2.38e-07 | 1443 | 150 | 30 | int:CEBPB |
| Interaction | SRSF1 interactions | KIF23 CEBPB SF3A1 HMGB1 NCL BRD3 ZC3H18 HNRNPU METTL14 SNIP1 BRCA1 SUB1 PRRC2C H1-4 PAK1IP1 USP48 TOP1 EP300 | 2.57e-07 | 570 | 150 | 18 | int:SRSF1 |
| Interaction | PHIP interactions | NOLC1 KIF23 TUT4 TRPS1 BRD3 AKAP8L PYHIN1 CEP170 PBRM1 ZFHX3 TAF1 | 2.69e-07 | 197 | 150 | 11 | int:PHIP |
| Interaction | MYCN interactions | NOLC1 MAP2 FXR2 RSL1D1 SF3A1 BAZ1B HMGB1 NCL LRRC59 ZC3H18 CBX4 GPATCH8 ADAR AKAP8L HNRNPU CEP170 CSDE1 SNIP1 BBX BRCA1 SUB1 IGHG1 PRRC2C H1-2 H1-4 SLTM PAK1IP1 TOP1 EP300 | 2.82e-07 | 1373 | 150 | 29 | int:MYCN |
| Interaction | PRPF3 interactions | ELOA CEBPB SF3A1 NCL BRD3 LRRC59 ZC3H18 PYHIN1 SNIP1 BRCA1 SPEN TOP1 EP300 | 2.85e-07 | 291 | 150 | 13 | int:PRPF3 |
| Interaction | RPL19 interactions | DCAF1 NOLC1 KIF23 CEBPB RSL1D1 TCEAL5 HMGB1 SRPRA NCL LRRC59 ZC3H18 HNRNPU METTL14 PYHIN1 H1-8 MICALL2 H1-4 RBM5 PAK1IP1 | 2.86e-07 | 638 | 150 | 19 | int:RPL19 |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.08e-05 | 9 | 93 | 3 | 1280 | |
| GeneFamily | AT-rich interaction domain containing | 5.73e-05 | 15 | 93 | 3 | 418 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.56e-04 | 4 | 93 | 2 | 1145 | |
| GeneFamily | PWWP domain containing | 1.89e-04 | 22 | 93 | 3 | 1147 | |
| GeneFamily | Ferlin family | 3.87e-04 | 6 | 93 | 2 | 828 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 9.20e-04 | 9 | 93 | 2 | 1203 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.39e-03 | 17 | 93 | 2 | 486 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TUT4 WAPL ARID4B EML4 ZNF652 SF3A1 TRPS1 AAK1 NSD1 UBA2 BAZ1B HMGB1 SRPRA GPATCH8 ADAR RGS2 HNRNPU PYHIN1 CSDE1 HIVEP3 JARID2 BBX SETD5 SUB1 ANKRD11 ELF1 PCNX1 BOD1L1 SPEN SMAP2 EP300 | 3.88e-10 | 1492 | 151 | 31 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | TUT4 NCL BRD3 RGS2 PYHIN1 CSDE1 PBRM1 NFE2L1 PRRC2C RALBP1 ELF1 BOD1L1 TNFAIP2 RAB13 | 1.51e-07 | 418 | 151 | 14 | MM3752 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | KIF23 TUT4 WAPL BAZ1B CEP170 JARID2 DST BBX ARID5B NAV3 ELF1 SPEN | 1.85e-07 | 300 | 151 | 12 | M8702 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KIF23 TUT4 ARID4B CAST APC BAZ1B HMGB1 NCL DZIP1 CEP170 PBRM1 BBX BRCA1 RALBP1 CDK5RAP2 USP48 PALLD | 2.62e-07 | 656 | 151 | 17 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KIF23 TUT4 WAPL APC BAZ1B GPATCH8 CEP170 JARID2 AFAP1 DST BBX BRCA1 PRRC2C ARID5B NAV3 ZFHX3 SPEN TOP1 RAD23B | 5.28e-07 | 856 | 151 | 19 | M4500 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | WAPL CEBPB ARID4B RSL1D1 ABCC5 GPATCH8 SERPINH1 RGS2 AKAP8L SNIP1 DST SETD5 ELF1 PCNX1 ANKRD12 PALLD EP300 AFF4 | 1.30e-06 | 822 | 151 | 18 | M6782 |
| Coexpression | TAKAO_RESPONSE_TO_UVB_RADIATION_DN | 1.63e-06 | 98 | 151 | 7 | M17860 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP | 3.00e-06 | 324 | 151 | 11 | M41138 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 3.24e-06 | 206 | 151 | 9 | M39254 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | KIF23 TUT4 WAPL CEP170 JARID2 AFAP1 DST BBX BRCA1 PRRC2C ARID5B SPEN RAD23B | 3.25e-06 | 466 | 151 | 13 | M13522 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NOLC1 AFF3 CBX4 DZIP1 HNRNPU PRRC2C H1-2 ARID5B H1-4 CDK5RAP2 ZFHX3 TAF1 PALLD | 3.33e-06 | 467 | 151 | 13 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NOLC1 AFF3 CBX4 DZIP1 HNRNPU PRRC2C H1-2 ARID5B H1-4 CDK5RAP2 ZFHX3 TAF1 PALLD | 4.90e-06 | 484 | 151 | 13 | MM999 |
| Coexpression | GSE37301_PRO_BCELL_VS_CD4_TCELL_UP | 6.71e-06 | 170 | 151 | 8 | M8893 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | TPP2 ANK3 EML4 AFF3 HMGB1 TTC3 BBX PRRC2C ANKRD12 METTL16 AFF4 | 8.82e-06 | 363 | 151 | 11 | M41103 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 9.29e-06 | 84 | 151 | 6 | M15130 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 1.06e-05 | 86 | 151 | 6 | MM825 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.38e-05 | 90 | 151 | 6 | M39250 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TPP2 ATXN7L2 ANK3 ABCC5 DZIP1 MAPK8IP3 AFAP1 DST BRCA1 AEBP1 PRRC2C H1-2 SCN8A NAV3 RBM5 ELF1 PCNX1 ZFHX3 ANKRD12 | 2.01e-05 | 1102 | 151 | 19 | M2369 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 2.11e-05 | 199 | 151 | 8 | M9443 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 2.11e-05 | 199 | 151 | 8 | M1746 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TUT4 ANK3 MAP2 TCEAL5 AFF3 APC ABCC5 SALL4 CBX4 TTC3 HIVEP3 SH3PXD2A SCN8A TENM1 NAV3 ZFHX3 BOD1L1 ANKRD12 SPAG17 | 2.11e-05 | 1106 | 151 | 19 | M39071 |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN | 2.18e-05 | 200 | 151 | 8 | M8039 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | 2.18e-05 | 200 | 151 | 8 | M9925 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 2.18e-05 | 200 | 151 | 8 | MM1033 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN | CEBPB ANK3 RSL1D1 EGLN1 CAST CBX4 TTC3 HNRNPU AFAP1 ARID5B SEC16A PLAGL1 TNFAIP2 EP300 | 2.44e-05 | 648 | 151 | 14 | M14371 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TPP2 ATXN7L2 ANK3 ABCC5 DZIP1 MAPK8IP3 AFAP1 DST BRCA1 AEBP1 PRRC2C H1-2 SCN8A NAV3 RBM5 ELF1 PCNX1 ZFHX3 ANKRD12 | 2.64e-05 | 1124 | 151 | 19 | MM1070 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 2.79e-05 | 207 | 151 | 8 | MM475 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.31e-05 | 212 | 151 | 8 | M39221 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | ARID4B ANK3 MAP2 CAST ABCC5 SALL4 FAM83B BCLAF3 PLA2R1 ARID5B ADGRF4 PALLD | 3.75e-05 | 504 | 151 | 12 | M2157 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP | 4.43e-05 | 162 | 151 | 7 | M8883 | |
| Coexpression | FISCHER_DREAM_TARGETS | DCAF1 NOLC1 PTTG1 KIF23 GAS2L3 PARP2 BAZ1B HMGB1 HNRNPU PBRM1 BRCA1 H1-2 CDK5RAP2 METTL16 TOP1 IQGAP3 RAD23B | 4.57e-05 | 969 | 151 | 17 | M149 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | NOLC1 ARID4B BAZ1B SRPRA NCL LRRC59 GHR RBM5 MLLT1 PLAGL1 METTL16 USP48 | 4.97e-05 | 519 | 151 | 12 | M3395 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | PTTG1 CAST HMGB1 NCL RRBP1 FER1L6 DST RALBP1 SLTM PALLD TOP1 | 7.37e-05 | 458 | 151 | 11 | M40010 |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 7.47e-05 | 380 | 151 | 10 | M41703 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | NOLC1 ARID4B BAZ1B SRPRA NCL LRRC59 GHR RBM5 MLLT1 PLAGL1 METTL16 USP48 | 7.65e-05 | 543 | 151 | 12 | MM997 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | TPP2 FXR2 NAPG UBA2 BAZ1B NCL BRD3 LRRC59 ZC3H18 HNRNPU MAPK8IP3 INTS10 SETD5 SUB1 RALBP1 SLTM USP48 RAD23B | 9.20e-05 | 1129 | 151 | 18 | M42508 |
| Coexpression | GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN | 9.64e-05 | 127 | 151 | 6 | M2915 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 9.95e-05 | 318 | 151 | 9 | M41707 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 1.06e-04 | 186 | 151 | 7 | M8175 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.07e-04 | 81 | 151 | 5 | M39253 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 1.19e-04 | 132 | 151 | 6 | MM465 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | TPP2 FXR2 NAPG UBA2 BAZ1B NCL BRD3 LRRC59 ZC3H18 HNRNPU MAPK8IP3 INTS10 SETD5 SUB1 RALBP1 SLTM USP48 RAD23B | 1.26e-04 | 1158 | 151 | 18 | MM1338 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.27e-04 | 84 | 151 | 5 | M13008 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 1.42e-04 | 195 | 151 | 7 | M1110 | |
| Coexpression | FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE | 1.44e-04 | 18 | 151 | 3 | M41040 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NOLC1 TPP2 RSL1D1 PARP2 CAST APC UBA2 BAZ1B NCL ADAR INTS10 JARID2 BRCA1 PRRC2C RALBP1 H1-4 ELF1 TAF1 TOP1 EP300 | 1.54e-04 | 1394 | 151 | 20 | M9585 |
| Coexpression | GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 1.61e-04 | 199 | 151 | 7 | M298 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN | 1.61e-04 | 199 | 151 | 7 | M8430 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 1.61e-04 | 199 | 151 | 7 | M8974 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | TPP2 CEBPB EML4 CBX4 METTL14 JARID2 BBX H1-2 BOD1L1 METTL16 TOP1 EP300 AFF4 | 1.63e-04 | 680 | 151 | 13 | M41089 |
| Coexpression | GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP | 1.66e-04 | 200 | 151 | 7 | M5842 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.66e-04 | 200 | 151 | 7 | M8635 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.66e-04 | 200 | 151 | 7 | M5901 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 1.66e-04 | 200 | 151 | 7 | M6552 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_DN | 1.66e-04 | 200 | 151 | 7 | M7840 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 1.66e-04 | 200 | 151 | 7 | M9258 | |
| Coexpression | MILI_PSEUDOPODIA | 1.69e-04 | 48 | 151 | 4 | M17507 | |
| Coexpression | FAN_OVARY_CL18_B_LYMPHOCYTE | 1.76e-04 | 422 | 151 | 10 | M41720 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.78e-04 | 142 | 151 | 6 | M6489 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 1.83e-04 | 49 | 151 | 4 | M17173 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.99e-04 | 145 | 151 | 6 | M1810 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.12e-04 | 432 | 151 | 10 | M41149 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 2.14e-04 | 51 | 151 | 4 | MM647 | |
| Coexpression | MILI_PSEUDOPODIA | 2.14e-04 | 51 | 151 | 4 | MM824 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | CEBPB GAS2L3 ZNF689 LRRC59 CEP170 CSDE1 PLAGL1 PAK1IP1 SPEN SMAP2 | 2.24e-04 | 435 | 151 | 10 | M41115 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 2.32e-04 | 437 | 151 | 10 | M4665 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | DCAF1 ELOA TUT4 WAPL HIVEP3 SNIP1 AFAP1 PBRM1 SETD5 SH3PXD2A BOD1L1 SPEN USP48 SMAP2 | 2.48e-04 | 807 | 151 | 14 | M14594 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP | 2.66e-04 | 22 | 151 | 3 | M40867 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | DCAF1 TPP2 ELOA PTTG1 KIF23 EGLN1 HMGB1 RGS2 HNRNPU JARID2 SETD5 SUB1 ARID5B H1-4 RBM5 ELF1 USP48 SMAP2 | 2.89e-04 | 1239 | 151 | 18 | M1743 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE | 2.95e-04 | 368 | 151 | 9 | M41100 | |
| Coexpression | MANALO_HYPOXIA_DN | 3.03e-04 | 292 | 151 | 8 | M18562 | |
| Coexpression | LIAO_METASTASIS | GAS2L3 NUMBL MAP2 TRPS1 SERPINH1 MICALL1 AEBP1 SCN8A NAV3 PLAGL1 USP48 | 3.08e-04 | 540 | 151 | 11 | M13809 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | CEBPB GAS2L3 ZNF689 AFF3 LRRC59 RRBP1 RGS2 CEP170 JARID2 SNIP1 ELF1 PLAGL1 ZFHX3 ALAS1 TNFAIP2 PAK1IP1 TOP1 RAD23B | 3.21e-04 | 1250 | 151 | 18 | M41099 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 3.24e-04 | 295 | 151 | 8 | M39121 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 3.27e-04 | 159 | 151 | 6 | MM760 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN | 3.27e-04 | 159 | 151 | 6 | M2983 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_UP | 3.38e-04 | 160 | 151 | 6 | M2976 | |
| Coexpression | FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2 | 3.50e-04 | 161 | 151 | 6 | M41714 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 3.50e-04 | 161 | 151 | 6 | M6848 | |
| Coexpression | BROWNE_HCMV_INFECTION_8HR_UP | 3.61e-04 | 105 | 151 | 5 | M10695 | |
| Coexpression | JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN | 3.79e-04 | 302 | 151 | 8 | M38975 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | THAP5 MAP2 ZNF652 APC SRPRA CBX4 TTC3 CSDE1 DST BBX NFE2L1 PLAGL1 ANKRD12 USP48 AFF4 | 3.86e-04 | 946 | 151 | 15 | M39169 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 3.86e-04 | 164 | 151 | 6 | M13108 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | EML4 SF3A1 ZNF689 EGLN1 CBX4 RGS2 JARID2 SNIP1 BBX SUB1 PRRC2C ELF1 PCNX1 RAD23B | 3.88e-04 | 844 | 151 | 14 | M41129 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | NOLC1 PTTG1 KIF23 WAPL GAS2L3 CAST ABCC5 NCL LRRC59 BRCA1 MICALL2 RALBP1 EIF2B3 PAK1IP1 USP48 TOP1 RAB13 RAD23B | 3.92e-04 | 1271 | 151 | 18 | M39197 |
| Coexpression | GAUTAM_EYE_CORNEA_FIBROBLASTS | 3.99e-04 | 165 | 151 | 6 | M43617 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 4.02e-04 | 384 | 151 | 9 | M1865 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 4.10e-04 | 385 | 151 | 9 | M39264 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 4.12e-04 | 166 | 151 | 6 | M8129 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | DCAF1 TPP2 ELOA PTTG1 KIF23 EGLN1 HMGB1 RGS2 HNRNPU JARID2 SETD5 SUB1 ARID5B H1-4 RBM5 ELF1 USP48 SMAP2 | 4.14e-04 | 1277 | 151 | 18 | MM1032 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 4.55e-04 | 62 | 151 | 4 | M1125 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 4.64e-04 | 567 | 151 | 11 | M1097 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | PTTG1 MAP2 DZIP1 SERPINH1 RGS2 HNRNPU MICALL1 CEP170 NEFH IGHG1 PLAGL1 PAK1IP1 | 4.70e-04 | 662 | 151 | 12 | M8124 |
| Coexpression | ZHONG_PFC_C1_OPC | 4.75e-04 | 238 | 151 | 7 | M39096 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | NOLC1 PTTG1 KIF23 GAS2L3 RSL1D1 EGLN1 UBA2 BAZ1B NCL ADAR HNRNPU FAM83B GHR CEP170 AFAP1 BRCA1 SUB1 PRRC2C IQGAP3 | 4.82e-04 | 1407 | 151 | 19 | M14427 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 4.84e-04 | 394 | 151 | 9 | MM3724 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 4.99e-04 | 240 | 151 | 7 | M39236 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 5.59e-04 | 402 | 151 | 9 | MM1248 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 5.78e-04 | 177 | 151 | 6 | M39245 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 5.90e-04 | 323 | 151 | 8 | M9150 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ARID4B RBBP5 STAC3 APC UBA2 BAZ1B HMGB1 NCL AKAP8L HNRNPU BCLAF3 CEP170 RSPO3 BBX SETD5 SLTM CDK5RAP2 PLAGL1 BOD1L1 TAF1 TOP1 | 3.22e-09 | 629 | 149 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | DCAF1 TPP2 EFCAB5 PTTG1 TUT4 WAPL ARID4B MAP2 RSL1D1 EML4 STAC3 TCEAL5 TRPS1 NSD1 APC NCL DZIP1 HNRNPU BCLAF3 RSPO3 JARID2 SETD5 SLTM ZFHX3 BOD1L1 ANKRD12 TOP1 | 1.63e-07 | 1252 | 149 | 27 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DCAF1 TUT4 ARID4B MAP2 RSL1D1 STAC3 TCEAL5 TRPS1 APC BAZ1B SALL4 NCL AKAP8L HNRNPU BCLAF3 RSPO3 BBX SLTM CDK5RAP2 ZFHX3 BOD1L1 TAF1 TOP1 | 4.17e-07 | 989 | 149 | 23 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | KIF23 WAPL APC BAZ1B HMGB1 NCL KLHL41 HNRNPU DST BBX PRRC2C SLTM ANKRD11 ALAS1 TOP1 | 1.14e-06 | 469 | 149 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TUT4 ARID4B STAC3 TRPS1 APC BAZ1B NCL HNRNPU BCLAF3 RSPO3 SLTM CDK5RAP2 BOD1L1 TOP1 | 2.26e-06 | 432 | 149 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TUT4 WAPL ARID4B STAC3 TCEAL5 TRPS1 NCL DZIP1 RGS2 PYHIN1 AEBP1 SH3PXD2A ARID5B SLTM NAV3 ALAS1 ANKRD12 TOP1 | 4.95e-06 | 744 | 149 | 18 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 1.22e-05 | 152 | 149 | 8 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | TUT4 ARID4B STAC3 BAZ1B NCL HNRNPU AFAP1 BRCA1 SLTM BOD1L1 TOP1 | 1.28e-05 | 311 | 149 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | DCAF1 NOLC1 TPP2 TUT4 ARID4B ANK3 RSL1D1 TCEAL5 TRPS1 NSD1 APC BAZ1B NCL DZIP1 HNRNPU JARID2 BRCA1 SETD5 SUB1 SLTM ZFHX3 BOD1L1 TOP1 | 1.83e-05 | 1241 | 149 | 23 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | DCAF1 NOLC1 TPP2 TUT4 WAPL ARID4B RSL1D1 TRPS1 NSD1 APC BAZ1B NCL HNRNPU BCLAF3 JARID2 BRCA1 FAM83F SETD5 SCN8A SLTM ZFHX3 BOD1L1 TOP1 | 2.24e-05 | 1257 | 149 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | DCAF1 NOLC1 TPP2 TUT4 WAPL ARID4B MAP2 RSL1D1 TRPS1 NSD1 APC BAZ1B SALL4 NCL HNRNPU BCLAF3 JARID2 BRCA1 FAM83F SETD5 SCN8A SLTM ZFHX3 BOD1L1 TOP1 | 2.84e-05 | 1459 | 149 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | TUT4 WAPL MAP2 AFF3 DZIP1 RGS2 MAPK8IP3 GHR CEP170 RSPO3 SUB1 SH3PXD2A H1-2 ANKRD11 PLAGL1 ZFHX3 ANKRD12 | 4.17e-05 | 791 | 149 | 17 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.19e-05 | 186 | 149 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.80e-05 | 249 | 149 | 9 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 6.97e-05 | 194 | 149 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ARID4B RBBP5 PARP2 APC BAZ1B HMGB1 GPATCH8 METTL14 CEP170 SETD5 CDK5RAP2 BOD1L1 TAF1 EP300 | 7.98e-05 | 595 | 149 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | TUT4 WAPL STAC3 TCEAL5 TRPS1 BAZ1B NCL DZIP1 RGS2 PYHIN1 AEBP1 ARID5B SLTM BOD1L1 ALAS1 ANKRD12 TOP1 | 7.99e-05 | 834 | 149 | 17 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | DCAF1 NOLC1 TPP2 TUT4 ARID4B ANK3 RSL1D1 TCEAL5 TRPS1 NSD1 APC BAZ1B SALL4 NCL DZIP1 HNRNPU JARID2 BRCA1 SETD5 SUB1 SLTM ZFHX3 BOD1L1 TOP1 | 8.77e-05 | 1468 | 149 | 24 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | MAP2 AFF3 DZIP1 RGS2 GHR RSPO3 SUB1 H1-2 ANKRD11 PLAGL1 ZFHX3 | 9.56e-05 | 388 | 149 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPP2 KIF23 WAPL NCL TTC3 HNRNPU BBX BRCA1 SUB1 PRRC2C SLTM ANKRD11 TOP1 | 9.95e-05 | 532 | 149 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | DCAF1 EFCAB5 NUMBL MAP2 AFF3 TRPS1 AAK1 DZIP1 SERPINH1 GHR RSPO3 SETD5 SH3PXD2A ARID5B SEC16A NAV3 PLAGL1 EGFLAM ANKRD12 EML1 PALLD | 1.09e-04 | 1208 | 149 | 21 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.53e-04 | 277 | 149 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.70e-04 | 281 | 149 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.63e-04 | 298 | 149 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 3.71e-04 | 188 | 149 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.00e-04 | 385 | 149 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 4.01e-04 | 136 | 149 | 6 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | EFCAB5 ZCWPW1 NUMBL MAP2 AFF3 AAK1 DZIP1 RRBP1 SERPINH1 FAM83B GHR RSPO3 SH3PXD2A NAV3 PLAGL1 EGFLAM ANKRD12 PALLD RAB13 | 4.40e-04 | 1148 | 149 | 19 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.99e-04 | 259 | 149 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | DCAF1 NOLC1 FXR2 RBBP5 RSL1D1 TRPS1 NAPG BAZ1B SALL4 NCL GPATCH8 AKAP8L SETD5 H1-2 H1-4 ANKRD11 TAF1 | 5.49e-04 | 983 | 149 | 17 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 TUT4 ARID4B MAP2 RSL1D1 EGLN1 STAC3 BAZ1B SALL4 NCL HNRNPU RSPO3 AFAP1 BRCA1 SLTM BOD1L1 TOP1 | 5.87e-04 | 989 | 149 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | DCAF1 EFCAB5 TUT4 ARID4B GAS2L3 NUMBL MAP2 FXR2 NSD1 APC GPATCH8 TTC3 HNRNPU JARID2 BRCA1 SETD5 SCN8A SLTM BOD1L1 EML1 TOP1 | 5.96e-04 | 1370 | 149 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 6.28e-04 | 408 | 149 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.68e-04 | 339 | 149 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 6.73e-04 | 150 | 149 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | ANK3 STAC3 TRPS1 DZIP1 RGS2 AEBP1 SH3PXD2A ARID5B NAV3 ZFHX3 ALAS1 ANKRD12 | 6.74e-04 | 567 | 149 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.18e-04 | 210 | 149 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TUT4 WAPL TRPS1 BAZ1B SALL4 NCL HNRNPU SLTM PLAGL1 BOD1L1 TOP1 | 7.23e-04 | 492 | 149 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | STAC3 TCEAL5 TRPS1 NCL DZIP1 RGS2 AEBP1 SH3PXD2A ARID5B NAV3 ZFHX3 ALAS1 ANKRD12 | 7.32e-04 | 655 | 149 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | ARID4B NCL ADAR HNRNPU CSDE1 IGHG1 PRRC2C H1-2 ARID5B H1-4 ANKRD11 ELF1 BOD1L1 ANKRD12 SMAP2 TOP1 AFF4 | 4.20e-19 | 200 | 152 | 17 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | WAPL ARID4B HMGB1 NCL PRRC2C RALBP1 SLTM ANKRD11 ELF1 ANKRD12 TNFAIP2 TOP1 | 2.28e-12 | 187 | 152 | 12 | 663991a8afe652e92363b64bcbd68c14d0307f0e |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TUT4 EML4 NSD1 APC BAZ1B RRBP1 PYHIN1 PRRC2C ANKRD11 ELF1 EP300 | 4.16e-11 | 184 | 152 | 11 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARID4B TRPS1 PBRM1 PRRC2C RALBP1 ARID5B SLTM ANKRD11 ELF1 PALLD TOP1 | 5.24e-11 | 188 | 152 | 11 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | WAPL ARID4B NSD1 NCL RRBP1 PRRC2C ARID5B ANKRD11 PLAGL1 ANKRD12 TOP1 | 7.35e-11 | 194 | 152 | 11 | e3d63874111d1e8da3977329426e4dcf68d6de87 |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | TUT4 ARID4B EML4 ADAR HNRNPU OTOF PRRC2C ANKRD11 ELF1 BOD1L1 ANKRD12 | 8.66e-11 | 197 | 152 | 11 | 5c33454b10023decd2f5ccda9229b6512659711e |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | TUT4 ARID4B EML4 ADAR HNRNPU OTOF PRRC2C ANKRD11 ELF1 BOD1L1 ANKRD12 | 9.14e-11 | 198 | 152 | 11 | 44417089b62056269cac38d3134ff209c05b7007 |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | TUT4 ARID4B EML4 ADAR HNRNPU OTOF PRRC2C ANKRD11 ELF1 BOD1L1 ANKRD12 | 9.14e-11 | 198 | 152 | 11 | 28ef3fc4c17dcb765537b75917f7db78baa522db |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ARID4B CAST NCL ADAR HNRNPU PRRC2C H1-4 ANKRD11 BOD1L1 ANKRD12 AFF4 | 1.02e-10 | 200 | 152 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.07e-10 | 171 | 152 | 10 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.23e-10 | 186 | 152 | 10 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.32e-09 | 193 | 152 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ARID4B ANK3 EML4 AAK1 HNRNPU PRRC2C ARID5B TENM1 ANKRD11 ANKRD12 | 1.61e-09 | 197 | 152 | 10 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | NCL RRBP1 NEFH PRRC2C H1-4 SLTM RBM5 CDK5RAP2 BOD1L1 ANKRD12 | 1.61e-09 | 197 | 152 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | NAPG TTC3 DST BBX PRRC2C RALBP1 ARID5B ANKRD11 BOD1L1 ANKRD12 | 1.78e-09 | 199 | 152 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.86e-09 | 200 | 152 | 10 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | TUT4 RSL1D1 STAC3 NCL KLHL41 RRBP1 HNRNPU PRRC2C BOD1L1 SPEN | 1.86e-09 | 200 | 152 | 10 | 7c261e39ac30b318511373ab7302aa53b8b81b9c |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-08 | 182 | 152 | 9 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-08 | 183 | 152 | 9 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-08 | 183 | 152 | 9 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-08 | 185 | 152 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.16e-08 | 192 | 152 | 9 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.58e-08 | 196 | 152 | 9 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.81e-08 | 198 | 152 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.94e-08 | 199 | 152 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | ARID4B CAST TTC3 PRRC2C RALBP1 ANKRD11 BOD1L1 ANKRD12 SPAG17 | 2.94e-08 | 199 | 152 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.94e-08 | 199 | 152 | 9 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.94e-08 | 199 | 152 | 9 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.40e-08 | 163 | 152 | 8 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 178 | 152 | 8 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-07 | 182 | 152 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.81e-07 | 188 | 152 | 8 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-07 | 190 | 152 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-07 | 191 | 152 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-07 | 191 | 152 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-07 | 191 | 152 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.30e-07 | 192 | 152 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-07 | 194 | 152 | 8 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-07 | 195 | 152 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 3.86e-07 | 196 | 152 | 8 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.16e-07 | 198 | 152 | 8 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.33e-07 | 199 | 152 | 8 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.33e-07 | 199 | 152 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 4.33e-07 | 199 | 152 | 8 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.33e-07 | 199 | 152 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.33e-07 | 199 | 152 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.49e-07 | 200 | 152 | 8 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 4.49e-07 | 200 | 152 | 8 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 4.49e-07 | 200 | 152 | 8 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 4.89e-07 | 138 | 152 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.21e-07 | 149 | 152 | 7 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.06e-06 | 171 | 152 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-06 | 174 | 152 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-06 | 181 | 152 | 7 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.47e-06 | 185 | 152 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-06 | 185 | 152 | 7 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 186 | 152 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 186 | 152 | 7 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 186 | 152 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 187 | 152 | 7 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 187 | 152 | 7 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|tumor_Lung / Location, Cell class and cell subclass | 4.28e-06 | 191 | 152 | 7 | 3e259eba83f8159d1a1a96b98d0e867fe547c5e7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.28e-06 | 191 | 152 | 7 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 4.28e-06 | 191 | 152 | 7 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-06 | 193 | 152 | 7 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-06 | 193 | 152 | 7 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | remission-Plasmablast|World / disease stage, cell group and cell class | 4.59e-06 | 193 | 152 | 7 | d62617c72863642f2222f7ed28bc6b90ee09b4e0 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-06 | 193 | 152 | 7 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.59e-06 | 193 | 152 | 7 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-06 | 193 | 152 | 7 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 4.59e-06 | 193 | 152 | 7 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-06 | 193 | 152 | 7 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.74e-06 | 194 | 152 | 7 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 195 | 152 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.91e-06 | 195 | 152 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.91e-06 | 195 | 152 | 7 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.07e-06 | 196 | 152 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 5.07e-06 | 196 | 152 | 7 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.07e-06 | 196 | 152 | 7 | e38036a5dbaed1488e01616bdc7678b28968470b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.25e-06 | 197 | 152 | 7 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 197 | 152 | 7 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 5.25e-06 | 197 | 152 | 7 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 3'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-06 | 197 | 152 | 7 | 03646005921bc330b7a9f66889ef1a7b9a3d530e | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 5.25e-06 | 197 | 152 | 7 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 198 | 152 | 7 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-06 | 198 | 152 | 7 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-06 | 198 | 152 | 7 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-06 | 198 | 152 | 7 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-06 | 198 | 152 | 7 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 198 | 152 | 7 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.42e-06 | 198 | 152 | 7 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-06 | 198 | 152 | 7 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-06 | 199 | 152 | 7 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.61e-06 | 199 | 152 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.61e-06 | 199 | 152 | 7 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 5.61e-06 | 199 | 152 | 7 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.61e-06 | 199 | 152 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.61e-06 | 199 | 152 | 7 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.79e-06 | 200 | 152 | 7 | fee909730133ec9875e14f7deed2a351dd21dba4 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 5.79e-06 | 200 | 152 | 7 | b0d708715f09ec1f67fdef3b100a91c8ff2747a7 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.49e-07 | 49 | 102 | 7 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.05e-04 | 50 | 102 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.38e-07 | 179 | 151 | 10 | 4585_DN | |
| Drug | torcetrapib | TPP2 ARID4B ANK3 EGLN1 TTC3 RGS2 DST PRRC2C ANKRD11 ELF1 BOD1L1 METTL16 PALLD | 4.92e-07 | 342 | 151 | 13 | ctd:C483909 |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 6.14e-07 | 191 | 151 | 10 | 4283_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | CYLC1 BAZ1B RRBP1 MAPK8IP3 RBM5 CDK5RAP2 ELF1 PCNX1 ALAS1 USP48 | 7.78e-07 | 196 | 151 | 10 | 5833_DN |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 3.81e-06 | 183 | 151 | 9 | 7062_DN | |
| Drug | E-PEG | NUMBL PARP2 ABCC5 NCL HNRNPU SNIP1 SUB1 CD99 H1-2 H1-4 RBM5 MLLT1 TNFAIP2 TAF1 TOP1 EP300 | 3.94e-06 | 621 | 151 | 16 | CID000003310 |
| Drug | Thimerosal | TPP2 ELOA WAPL EGLN1 APC HMGB1 SRPRA SALL4 KLHL41 SERPINH1 AKAP8L INTS10 NEFH DST CD99 PRRC2C H1-4 NAV3 PCNX1 BOD1L1 ALAS1 SPEN AFF4 | 4.28e-06 | 1199 | 151 | 23 | ctd:D013849 |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 5.17e-06 | 190 | 151 | 9 | 4307_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 5.87e-06 | 193 | 151 | 9 | 4321_DN | |
| Drug | bromfenacoum | NOLC1 ANK3 SF3A1 CAST AAK1 APC NAPG NCL LRRC59 ZC3H18 RRBP1 HNRNPU NEFH DST RALBP1 SEC16A | 6.23e-06 | 644 | 151 | 16 | ctd:C013418 |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 7.52e-06 | 199 | 151 | 9 | 2682_DN | |
| Drug | bis(tri-n-butyltin)oxide | NOLC1 CEBPB RSL1D1 AAK1 NCL SERPINH1 RGS2 HNRNPU NEFH BRCA1 SUB1 H1-2 PLAGL1 RAD23B | 1.46e-05 | 538 | 151 | 14 | ctd:C005961 |
| Drug | celastrol; Up 200; 2.5uM; MCF7; HT_HG-U133A_EA | 1.92e-05 | 171 | 151 | 8 | 887_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.46e-05 | 177 | 151 | 8 | 985_DN | |
| Drug | Chloroprene | TUT4 CEBPB EML4 AFF3 TRPS1 AAK1 TTC3 SERPINH1 RGS2 HNRNPU PYHIN1 HIVEP3 PBRM1 BBX AEBP1 SETD5 ARID5B SLTM ANKRD11 RBM5 ALAS1 ANKRD12 AFF4 | 2.81e-05 | 1348 | 151 | 23 | ctd:D002737 |
| Drug | loxistatin acid | 2.92e-05 | 54 | 151 | 5 | CID000003188 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.00e-05 | 182 | 151 | 8 | 3887_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.12e-05 | 183 | 151 | 8 | 7498_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.24e-05 | 184 | 151 | 8 | 6755_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; HL60; HG-U133A | 3.50e-05 | 186 | 151 | 8 | 1548_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.50e-05 | 186 | 151 | 8 | 3279_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 3.64e-05 | 187 | 151 | 8 | 7080_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.78e-05 | 188 | 151 | 8 | 6735_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 3.78e-05 | 188 | 151 | 8 | 4310_DN | |
| Drug | 1-phenylpentan-3-amine | 3.88e-05 | 29 | 151 | 4 | CID005195771 | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.08e-05 | 190 | 151 | 8 | 4507_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 4.08e-05 | 190 | 151 | 8 | 4114_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.08e-05 | 190 | 151 | 8 | 4322_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.23e-05 | 191 | 151 | 8 | 6020_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.23e-05 | 191 | 151 | 8 | 3926_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 4.39e-05 | 192 | 151 | 8 | 4110_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.39e-05 | 192 | 151 | 8 | 1646_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.55e-05 | 193 | 151 | 8 | 4305_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 4361_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 4.72e-05 | 194 | 151 | 8 | 2009_DN | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 4.90e-05 | 195 | 151 | 8 | 681_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 7276_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 2298_DN | |
| Drug | pentamidine isethionate salt; Down 200; 100uM; MCF7; HG-U133A | 5.26e-05 | 197 | 151 | 8 | 639_DN | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 2103_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 5220_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 5.46e-05 | 198 | 151 | 8 | 1070_DN | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; PC3; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 6297_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 6624_DN | |
| Drug | NSC351140 | 5.84e-05 | 258 | 151 | 9 | CID000002210 | |
| Drug | Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 5.86e-05 | 200 | 151 | 8 | 6264_UP | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 5.86e-05 | 200 | 151 | 8 | 6449_DN | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HG-U133A | 5.86e-05 | 200 | 151 | 8 | 1955_DN | |
| Drug | AC1L18R8 | 7.22e-05 | 105 | 151 | 6 | CID000050261 | |
| Drug | Topo | 7.41e-05 | 153 | 151 | 7 | CID000065577 | |
| Drug | AC1MM84E | 7.75e-05 | 66 | 151 | 5 | CID003256856 | |
| Drug | Thapsigargin | NOLC1 TPP2 PTTG1 ZCWPW1 CEBPB ARID4B RSL1D1 BAZ1B SRPRA RRBP1 SERPINH1 AKAP8L HMGB1P1 NEFH AFAP1 BRCA1 H1-2 H1-4 RBM5 CDK5RAP2 TAF1 RAD23B | 8.70e-05 | 1353 | 151 | 22 | ctd:D019284 |
| Drug | testosterone enanthate | ELOA ANK3 FXR2 RBBP5 RSL1D1 GPATCH8 RRBP1 TTC3 BBX PRRC2C ELF1 SPEN PALLD | 1.24e-04 | 575 | 151 | 13 | ctd:C004648 |
| Drug | NSC302991 | 1.28e-04 | 353 | 151 | 10 | CID000002538 | |
| Drug | 4,4'-dipyridylamine | 1.31e-04 | 3 | 151 | 2 | CID000225529 | |
| Drug | Gaviscon | 1.31e-04 | 3 | 151 | 2 | CID006336690 | |
| Drug | R165481 | 1.50e-04 | 16 | 151 | 3 | CID005459348 | |
| Drug | bu-b | 1.62e-04 | 77 | 151 | 5 | CID000351065 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.65e-04 | 174 | 151 | 7 | 7530_DN | |
| Drug | 5-methylcytosine | 1.69e-04 | 233 | 151 | 8 | CID000065040 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.90e-04 | 178 | 151 | 7 | 3998_DN | |
| Drug | geldanamycin | 1.92e-04 | 371 | 151 | 10 | ctd:C001277 | |
| Drug | Stallimycin | 1.93e-04 | 80 | 151 | 5 | CID000003115 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.04e-04 | 180 | 151 | 7 | 4541_DN | |
| Drug | Zlllal | TPP2 CAST UBA2 NCL AKAP8L GHR BRCA1 H1-2 H1-4 TNFAIP2 PALLD TOP1 EP300 | 2.32e-04 | 613 | 151 | 13 | CID000107707 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.33e-04 | 184 | 151 | 7 | 2321_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.33e-04 | 184 | 151 | 7 | 4610_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 184 | 151 | 7 | 5671_DN | |
| Drug | AC1OCADI | 2.34e-04 | 130 | 151 | 6 | CID006914639 | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.41e-04 | 185 | 151 | 7 | 1114_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.41e-04 | 185 | 151 | 7 | 1673_DN | |
| Drug | domoic acid | 2.43e-04 | 84 | 151 | 5 | ctd:C012301 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.57e-04 | 187 | 151 | 7 | 4323_DN | |
| Drug | Alsterpaullone; Down 200; 10uM; MCF7; HT_HG-U133A | 2.57e-04 | 187 | 151 | 7 | 7051_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.74e-04 | 189 | 151 | 7 | 4271_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 2.74e-04 | 189 | 151 | 7 | 1288_DN | |
| Drug | Daunorubicin hydrochloride [23541-50-6]; Down 200; 7uM; MCF7; HT_HG-U133A | 2.83e-04 | 190 | 151 | 7 | 4983_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.83e-04 | 190 | 151 | 7 | 4306_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.92e-04 | 191 | 151 | 7 | 4303_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.92e-04 | 191 | 151 | 7 | 2824_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.92e-04 | 191 | 151 | 7 | 7435_DN | |
| Drug | arsenic trioxide | PTTG1 ANK3 ABCC5 RRBP1 RGS2 AFAP1 H1-2 H1-4 NAV3 ANKRD12 EP300 | 2.99e-04 | 468 | 151 | 11 | CID000014888 |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 3.02e-04 | 192 | 151 | 7 | 4311_DN | |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.02e-04 | 192 | 151 | 7 | 3526_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.11e-04 | 193 | 151 | 7 | 6749_DN | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 3.11e-04 | 193 | 151 | 7 | 6920_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 3321_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 4281_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 6243_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 6199_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 3525_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 3559_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 4508_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; HL60; HG-U133A | 3.31e-04 | 195 | 151 | 7 | 1627_UP | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 6626_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 6648_DN | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 1276_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 3716_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; HL60; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 2339_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 5728_DN | |
| Disease | brain measurement, neuroimaging measurement | ANK3 MAP2 RBBP5 TRPS1 GPATCH8 MOB2 AFAP1 PBRM1 SH3PXD2A NAV3 ZFHX3 EML1 RAD23B | 4.74e-06 | 550 | 149 | 13 | EFO_0004346, EFO_0004464 |
| Disease | Adenoid Cystic Carcinoma | 1.21e-05 | 100 | 149 | 6 | C0010606 | |
| Disease | FEV/FEC ratio | EFCAB5 MAP2 RBBP5 EML4 AFF3 TRPS1 NSD1 NAPG RRBP1 HMGB1P1 FAM83B HIVEP3 RSPO3 AFAP1 DST SH3PXD2A ANKRD11 ZFHX3 RAD23B | 1.46e-05 | 1228 | 149 | 19 | EFO_0004713 |
| Disease | Benign tumor of pancreas | 3.48e-05 | 13 | 149 | 3 | C0347284 | |
| Disease | platelet crit | ZCWPW1 ARID4B MYH13 AFF3 ABCC5 ZC3H18 GPATCH8 RRBP1 HMGB1P1 PLA2R1 BBX NFE2L1 ARID5B NAV3 ELF1 | 1.00e-04 | 952 | 149 | 15 | EFO_0007985 |
| Disease | Neurodevelopmental Disorders | 1.12e-04 | 93 | 149 | 5 | C1535926 | |
| Disease | Malignant neoplasm of breast | TTC3 ADAR RGS2 MICALL1 RSPO3 PBRM1 BRCA1 OTOF FAM83F H1-2 TENM1 BOD1L1 ADGRF4 SPEN TOP1 EP300 | 1.12e-04 | 1074 | 149 | 16 | C0006142 |
| Disease | Pancreatic carcinoma | 1.15e-04 | 19 | 149 | 3 | C0235974 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 2.51e-04 | 5 | 149 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | testosterone measurement | ZCWPW1 ANK3 FXR2 EML4 ZNF652 TRPS1 CAST BAZ1B ADAR RSPO3 BBX SH3PXD2A ARID5B PLAGL1 ZFHX3 METTL16 USP48 | 2.54e-04 | 1275 | 149 | 17 | EFO_0004908 |
| Disease | neuroimaging measurement | ANK3 MAP2 RBBP5 AFF3 TRPS1 APC MAPK8IP3 AFAP1 BRCA1 SH3PXD2A PRRC2C H1-2 NAV3 EML1 RAD23B | 3.50e-04 | 1069 | 149 | 15 | EFO_0004346 |
| Disease | Intellectual Disability | 4.67e-04 | 447 | 149 | 9 | C3714756 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 5.23e-04 | 7 | 149 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | twisted gastrulation protein homolog 1 measurement | 6.95e-04 | 8 | 149 | 2 | EFO_0803205 | |
| Disease | microcephaly (is_implicated_in) | 6.95e-04 | 8 | 149 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Pancreatic carcinoma, familial | 8.91e-04 | 9 | 149 | 2 | C2931038 | |
| Disease | smoking behavior, BMI-adjusted waist-hip ratio | 9.62e-04 | 86 | 149 | 4 | EFO_0004318, EFO_0007788 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.11e-03 | 10 | 149 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.11e-03 | 10 | 149 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | AFF3 BRD3 MAPK8IP3 HIVEP3 AFAP1 SH3PXD2A ARID5B ZFHX3 BOD1L1 | 1.17e-03 | 509 | 149 | 9 | EFO_0004695 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.17e-03 | 41 | 149 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.17e-03 | 41 | 149 | 3 | C0858252 | |
| Disease | Prostatic Neoplasms | 1.19e-03 | 616 | 149 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.19e-03 | 616 | 149 | 10 | C0376358 | |
| Disease | C-reactive protein measurement | RPGRIP1 ANK3 TRPS1 CAST BAZ1B NCL BRD3 ADAR MAPK8IP3 RSPO3 SETD5 SEC16A KIAA2012 TOP1 AFF4 | 1.20e-03 | 1206 | 149 | 15 | EFO_0004458 |
| Disease | colorectal cancer (is_marker_for) | 1.24e-03 | 157 | 149 | 5 | DOID:9256 (is_marker_for) | |
| Disease | obsolete_red blood cell distribution width | TPP2 ZCWPW1 FXR2 RBBP5 ABCC5 BRD3 HMGB1P1 CEP170 INTS10 RSPO3 PBRM1 NFE2L1 PRRC2C H1-2 ANKRD12 EP300 | 1.32e-03 | 1347 | 149 | 16 | EFO_0005192 |
| Disease | mean fractional anisotropy measurement | 1.39e-03 | 95 | 149 | 4 | EFO_0008399 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.62e-03 | 12 | 149 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Pancreatic Neoplasm | 1.68e-03 | 100 | 149 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 1.81e-03 | 102 | 149 | 4 | C0346647 | |
| Disease | Leukemia, Myelocytic, Acute | 1.90e-03 | 173 | 149 | 5 | C0023467 | |
| Disease | corneal resistance factor | 2.14e-03 | 451 | 149 | 8 | EFO_0010067 | |
| Disease | aspartate aminotransferase measurement | RBBP5 CAST NSD1 BRD3 ZC3H18 RRBP1 RSPO3 BRCA1 NFE2L1 IGHG1 ELF1 KIAA2012 | 2.19e-03 | 904 | 149 | 12 | EFO_0004736 |
| Disease | unipolar depression, mood disorder, response to antidepressant | 2.21e-03 | 14 | 149 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | breast cancer (is_marker_for) | 2.54e-03 | 185 | 149 | 5 | DOID:1612 (is_marker_for) | |
| Disease | hepatoblastoma (is_marker_for) | 2.55e-03 | 15 | 149 | 2 | DOID:687 (is_marker_for) | |
| Disease | R-6-hydroxywarfarin measurement | 2.71e-03 | 114 | 149 | 4 | EFO_0803327 | |
| Disease | cholesterol in medium HDL measurement | 3.34e-03 | 59 | 149 | 3 | EFO_0021903 | |
| Disease | brain volume measurement | 3.34e-03 | 595 | 149 | 9 | EFO_0006930 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.36e-03 | 121 | 149 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | body fat percentage | 3.46e-03 | 488 | 149 | 8 | EFO_0007800 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 3.56e-03 | 123 | 149 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | eosinophil count | ZNF652 SF3A1 ABCC5 HMGB1 BRD3 RRBP1 HIVEP3 PLA2R1 PBRM1 BRCA1 SEC16A ANKRD11 ELF1 PLAGL1 PCNX1 KIAA2012 | 3.57e-03 | 1488 | 149 | 16 | EFO_0004842 |
| Disease | age at onset, Parkinson disease | 3.67e-03 | 18 | 149 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | Liver carcinoma | 4.35e-03 | 507 | 149 | 8 | C2239176 | |
| Disease | breast carcinoma (is_marker_for) | 4.58e-03 | 66 | 149 | 3 | DOID:3459 (is_marker_for) | |
| Disease | total lipids in small VLDL | 4.77e-03 | 67 | 149 | 3 | EFO_0022148 | |
| Disease | squamous cell carcinoma | 4.77e-03 | 67 | 149 | 3 | EFO_0000707 | |
| Disease | central corneal thickness | 4.95e-03 | 309 | 149 | 6 | EFO_0005213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ANKAPGSKGVKQKSP | 536 | P51826 | |
| TGSPGKKEEKAKNKE | 836 | Q4LE39 | |
| LKSQTPKGGDKKESS | 816 | Q5SW79 | |
| QSSPAPGQSKKKIFK | 1036 | Q09472 | |
| EEEKKAKVAPPAKQA | 516 | Q15059 | |
| KPGNSKAAKPKDPVE | 346 | P32519 | |
| EVKPLPATKGGNKKF | 276 | Q63HQ2 | |
| GNDKVAPSKDPGKKD | 1551 | Q6UB99 | |
| PRKKKKTGNVSSEPT | 716 | Q8WY36 | |
| QDLDQPESPSAKKAK | 461 | A6NCI8 | |
| PVKASEAAAKKTQPK | 336 | Q2M2I8 | |
| TAAEVPPEKTKDKGK | 81 | Q8IUX7 | |
| GSPDRKPSKKSKTDN | 311 | Q9UIG0 | |
| KGKTLSSQPKKADPA | 526 | Q8N556 | |
| AAGGATPKKSAKKTP | 141 | P16403 | |
| KAGDKLQSPEGKPKT | 31 | Q8IZF3 | |
| PKTTSPNKGKEKEAE | 441 | O75534 | |
| ENKKPTAIPKKPSAG | 36 | P14209 | |
| KSEADKPKPKSSPAS | 1046 | Q6UB98 | |
| KANSRKGESPKEKSP | 286 | Q5T6C5 | |
| KGESPKEKSPGRKEQ | 291 | Q5T6C5 | |
| KKRKQGGSPDEPDSK | 276 | Q9ULX6 | |
| KPKTEDKNSAGHKPS | 781 | Q9UHB7 | |
| KANKKDTHDGPPKEI | 6 | Q8IWF9 | |
| QQPPGSKTIFSKEKK | 531 | Q96SN8 | |
| KKKAEAAAAPTVAPG | 241 | Q9Y6R0 | |
| PPSALKKGSKEKQAD | 591 | Q14494 | |
| KGQDPSGKKIKAEPD | 131 | P07205 | |
| GNKPPSTDLKTCDKK | 181 | P51153 | |
| SAAKQEKPAEKPAET | 141 | P54727 | |
| AKEQPKAGKEPAKPS | 631 | Q15311 | |
| DSKVKQSDPGKISEK | 1111 | Q96L73 | |
| AAKAPPKKAKSSDSD | 156 | Q14978 | |
| AAPSKPASAKKGKAE | 501 | Q14978 | |
| GKSQEEPSKVKPKFR | 531 | Q9NVR2 | |
| KAPVDPECTAKVGKA | 91 | Q9UGN5 | |
| GKSKAKPNGKKPAAE | 6 | Q70IA6 | |
| TTKPEDGGLKKNKSA | 256 | Q9Y4B6 | |
| GKPKSKDPLGADKQD | 261 | P0DN81 | |
| PQSTPKSAKGSAKKE | 1361 | Q86U86 | |
| SEAKEDPPNVGKVKK | 161 | Q8IZA3 | |
| KVVAKAKAPKAGQGP | 281 | Q8IZA3 | |
| AKIGTSSQGPSKKKP | 81 | Q3KP22 | |
| PKGETKKKFKDPNAP | 81 | P09429 | |
| GEPKSAHTSPEKKKA | 746 | Q9UPT6 | |
| QKGDSVSKLPKGPSE | 641 | P51116 | |
| TPPASEKDKTAKAKV | 61 | P13196 | |
| KPKKEANQAPKSKSG | 216 | Q96AG4 | |
| KDAEKAGKPPFSKQK | 1461 | Q03001 | |
| KNNPGKTKTLDPKAV | 266 | Q9HCE5 | |
| SNKELASKKEVKGSP | 751 | Q5T0W9 | |
| EEEPSGKKAPVQAAK | 126 | Q8IY33 | |
| KGSSPKPKSCIKAAA | 436 | Q9UKJ3 | |
| PPGNTAENKEEKSDK | 506 | Q96RV3 | |
| KTPGKTDDAKASEKG | 1011 | Q8IVL0 | |
| KPGAKKKIDESDGTS | 551 | P35663 | |
| ALPPEKKQNTGSKKS | 676 | Q00839 | |
| VEAGPPKAKGKTDKE | 96 | Q8N292 | |
| KDAFAGKLPEPSKNA | 256 | O60662 | |
| KGKKSPESQKGVDSP | 546 | Q0VF49 | |
| LEEKKPTPKESGNSQ | 406 | Q86W50 | |
| PAASPATKKATKGSK | 641 | Q8N3F8 | |
| KNGSKLPPASTSKKE | 456 | Q3SXY7 | |
| EKEKPSSPSSGKGKT | 361 | Q8TDV0 | |
| APQEKDTASKAPKDP | 411 | C9JSJ3 | |
| QSGLPPAKEGKEKKE | 516 | P52756 | |
| PDSKSSGKGKKQPSL | 1521 | Q86VI3 | |
| TPAKKAAVTPGKKAA | 76 | P19338 | |
| GKKAAATPAKKTVTP | 86 | P19338 | |
| KKRQSSADGSQPPKK | 436 | Q15291 | |
| EKRGAKTPSTNVKPK | 141 | Q8WX93 | |
| KSQDKGPKTGSVKKE | 806 | O15440 | |
| EAKSPAEVKSPEKAK | 571 | P12036 | |
| AEVKSPEKAKSPAKE | 576 | P12036 | |
| EAKSPAEAKSPEKAK | 591 | P12036 | |
| AEAKSPEKAKSPVKE | 596 | P12036 | |
| AKSPAEVKSPEKAKS | 626 | P12036 | |
| AKSPEKAKSPVKAEA | 666 | P12036 | |
| VKAEAKSPEKAKSPV | 676 | P12036 | |
| AKSPVKAEAKSPEKA | 686 | P12036 | |
| AKTPEKAKSPVKEEA | 736 | P12036 | |
| SKPPEKATEDKAAKG | 1011 | P12036 | |
| GKEPATGAKKSNKPN | 671 | P38398 | |
| GATKQATTPKPDKEK | 931 | Q8NFC6 | |
| DKPCEPKSQKIEGKS | 741 | A4FU69 | |
| QDSIEPVPGQKGKKK | 136 | Q9NR50 | |
| SAPSKKAAKDPGKGE | 96 | Q8TES7 | |
| GQVKEPFKPSKKDSI | 336 | A2AJT9 | |
| FPPAEAGSKKVAKQD | 546 | P55265 | |
| PGLKTNSSKEPKFTK | 41 | P10912 | |
| PKVNKTKSEKPAGAD | 481 | Q14241 | |
| KKKKTKGDNPNSHPE | 2656 | Q8TD26 | |
| KSSKGITKKPQAPSN | 386 | Q86XJ1 | |
| GAAPAPSQVKSKAKK | 251 | P17676 | |
| PQKRKKPSEEETGTK | 136 | Q6K0P9 | |
| PEAKKVAKEAAPEAS | 61 | Q8IX06 | |
| KKAAGAEEKKVEAPP | 311 | O00257 | |
| KGEHEPTPGKKKLQA | 741 | Q5T1N1 | |
| AAPLKSKSEKAGSEK | 4061 | Q12955 | |
| DAAKGKVKAKPPADP | 106 | Q9GZT9 | |
| KSQEGKPKEHTEPKS | 51 | P20810 | |
| GQDKPVKPPTKKSED | 626 | P20810 | |
| PKNGGKAKDSAKTTE | 686 | P20810 | |
| ATGAATPKKSAKKTP | 141 | P10412 | |
| KADLQDGKAPKSPSS | 136 | A0A1B0GTZ2 | |
| NHKPSNTKVDKKVEP | 86 | P01857 | |
| SGKKNSESKPKEPVF | 166 | O00423 | |
| AKSGTEKKKEKPQGQ | 111 | Q9HC35 | |
| DPKKTKPSHGSKDAN | 171 | Q03111 | |
| VALDTSKKGKGKPPN | 351 | Q9UJQ4 | |
| SKKGKGKPPNISAVD | 356 | Q9UJQ4 | |
| SGQGSEAPEKKKPKI | 1391 | Q9HC10 | |
| KTKGPLKQKQPSFSA | 76 | O95997 | |
| EPVQKHKSKEATPAK | 236 | Q92833 | |
| KPTVKKGSQTNLKDP | 11 | Q02241 | |
| NPKGKKGNTEAKPDE | 1231 | Q2WGJ9 | |
| GKKSKQQAFIKPSPE | 61 | P41220 | |
| AHAEEKPPSGTKEKK | 141 | Q9UM63 | |
| GNNKEKEVPAKEKPS | 211 | Q8TAD8 | |
| LKPEAQTKGKDTKDS | 936 | Q96KN7 | |
| KDDKEPQPVKKTVTG | 976 | P21675 | |
| PKGETKKKFKDPNAP | 81 | B2RPK0 | |
| SEGPKPEKVYKSKSE | 976 | Q9Y520 | |
| GKNVKITDSEASKPK | 266 | Q9NWH9 | |
| VKKPAAAAAPGTAEK | 21 | P50454 | |
| AAPKTKKIKNSPSEA | 181 | Q9C0A6 | |
| SPIGGKVSDKSEKKV | 376 | Q9UKZ4 | |
| PEKVGPKQAEDAAKS | 551 | Q9UBT2 | |
| VAPEKPVKKQKTGET | 31 | P53999 | |
| FKEGKAQEPSAAIPK | 101 | Q15459 | |
| KSGKEQKEPPPAKNE | 806 | Q86YF9 | |
| KSKAKAKAPAPAPAE | 86 | Q8NEG4 | |
| EKKKDTPKQHGTCPK | 946 | Q13018 | |
| KAPSAKPAKGKGKDQ | 171 | Q6Q759 | |
| KGKDQPEANAPVKKT | 181 | Q6Q759 | |
| TPAATPKSGKHKNKE | 141 | P55201 | |
| SKKEKENAPKPQDAA | 451 | Q14865 | |
| KAPTAEKRESGPKQA | 1456 | P25054 | |
| SKEKTKAPPNVKNEG | 1181 | Q9UHF7 | |
| KKKKGQPSSAEPEDA | 51 | Q03169 | |
| SDSDQPGPKKKFKAP | 536 | Q9H0M4 | |
| PEAPKQEAPAKKKSG | 616 | Q9P2E9 | |
| EVVEKKPAPEKNSKS | 2061 | Q96T58 | |
| PETKRPGQAAKKETK | 2086 | O15027 | |
| PGQAAKKETKEPKKG | 2091 | O15027 | |
| PGSKSEEIGKKQLSK | 251 | Q8WU79 | |
| KKKSPATPQAKPDGV | 281 | Q99747 | |
| KKPESKKEQTPEHGK | 331 | O76021 | |
| LNKKASGDKETPPAE | 351 | Q5TCZ1 | |
| LPEDNQGKDPSKKKS | 86 | Q7Z6K1 | |
| EDKPQSEGKPASQAK | 81 | Q5H9L2 | |
| TEEAHKKERKPQKPG | 176 | Q5T1R4 | |
| PPTKTKNGSKDKEKD | 996 | P29144 | |
| VVAPSPKTKGQKAED | 1931 | P53804 | |
| PESVKKPINKQGDKS | 521 | Q7Z5K2 | |
| QKPKPAKGKAEAHFS | 566 | Q9UKX3 | |
| KPPSPSSAEKVKANK | 51 | Q5SRE5 | |
| KKPNKGESKEAIPDS | 221 | Q9BXY4 | |
| SKPKPNSDLEAGKSL | 51 | Q9UQD0 | |
| STKSDAPKEKGKKAP | 231 | P08240 | |
| PVSKEQSKIGKKEPG | 321 | Q9NWT1 | |
| KQAKDKVSDGVTKSP | 1521 | P11137 | |
| RKKNGEKEVFPPKEA | 111 | Q96CS4 | |
| EKKKSKDQTGEVPQP | 36 | Q9UI33 | |
| ATKEPKAPVQKAKCE | 226 | Q9Y2D9 | |
| KAEKKTPDDKHKQPG | 231 | Q96MF2 | |
| AKAEKSPKSPNSVKA | 126 | Q5TAX3 | |
| AEPSKSQTRKPKCGK | 391 | Q86UV5 | |
| KIKKEKENGFSSPPQ | 101 | P11387 | |
| SPAPAQTRKEKGKSK | 746 | Q86VM9 | |
| VPKKEKGEAPTATAA | 3256 | Q15911 |